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ABSTRACT 
 
DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF  
AN INSTRUMENT TO ASSESS THE TREATMENT FIDELITY OF A  
BRIEF OPPORTUNISTIC INTERVENTION TO REDUCE SUBSTANCE USE  
AMONG PREGNANT WOMEN 
 
By 
Antonia Rae Torrey 
August 2011 
 
Dissertation supervised by Linda Goodfellow PhD, RN 
Although abstinence from alcohol, tobacco, and other drugs (ATOD) among 
pregnant women is a leading national objective, prenatal use has not decreased. 
Evidence-based interventions that can be replicated in practice are critically needed and 
brief interventions have shown promise in reducing prenatal ATOD use. The “I Am 
Concerned” (IAC) brief opportunistic intervention is currently being implemented by 
frontline primary prenatal care staff members in several areas of the United States. 
Evaluation of treatment fidelity, to determine if behavioral interventions are delivered as 
intended, is essential to controlled research. This study constituted the first step in the 
development and psychometric evaluation of an instrument designed to measure the 
treatment fidelity with which the IAC brief opportunistic intervention is implemented. A 
conceptual framework derived from motivational interviewing and self-determination 
 v 
theory, both based on the fundamental assumption that individuals are inherently inclined 
toward positive change, guided operationalization of the IAC behavioral elements that 
ultimately took shape as the 18-item IAC treatment fidelity instrument. 
This methodologic study used a 6-phase protocol to develop and refine the IAC 
treatment fidelity instrument and evaluate its psychometric properties. Independent raters 
used the instrument to evaluate audio recordings (N = 49) of experienced frontline staff 
members implementing the IAC brief opportunistic intervention with standardized 
patients portraying ATOD-using pregnant women in a simulated clinic setting.  
Psychometric analysis provided evidence of content validity. Intra-class 
correlation coefficients (ICC) calculated for inter-rater reliability were satisfactory for 
subscales (0.64) and (0.62) and ranged from -0.07 to 0.81 for individual items. Internal 
consistency alpha coefficients were satisfactory for the total scale (0.72) and lower than 
acceptable for adherence (0.54) and competence (0.56) subscales. Overall high rater 
percentage agreement and negatively skewed ratings distribution indicated that reliability 
results were paradoxically low due to the base rate problem. The study results support 
revision and ongoing testing of the IAC treatment fidelity instrument. 
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 1 
Chapter I 
Introduction 
Statement of the Problem 
Prenatal substance use is a foremost public health concern that transcends societal 
boundaries (Chasnoff, Landress, & Barrett, 1990; Vega, Kolody, Hwang, & Noble, 
1993), affecting not only the pregnant woman and her fetus, but her family and 
community as well (Ettlinger, 2000; Reis, Mills-Thomas, Robinson, & Anderson, 1992; 
Sun, 2004). Negative sequelae associated with prenatal use of alcohol, tobacco, or other 
drugs (ATOD) have been well established (Armstrong et al., 2003; Bennett, 1999; 
Mahony, 1998; Redding & Selleck, 1993; Shiono et al., 1995). Prenatal ATOD exposure 
has been linked to significant fetal complications including prematurity (Shiono, 
Klebanoff, & Rhoads, 1986), brain damage (Riley, McGee, & Sowell, 2004), and 
intrauterine death (Mahony, 1998). Neurobehavioral teratogenic effects associated with 
prenatal substance exposure include impaired executive function (Fried, 2002), lifelong 
learning disabilities, and mental retardation (Streissguth et al., 1991). 
Abstinence from alcohol, cigarettes, and illicit drugs among pregnant women are 
leading maternal and infant health objectives that have been targeted in the agendas set 
by Healthy People 2000, 2010 (Centers for Disease Control and Prevention, 2000). 
Despite this national focus, prenatal use of these substances has not decreased (Substance 
Abuse and Mental Health Services Administration, 2003, 2004, 2005, 2006, 2007, 2008, 
2009, 2010).
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Background 
Pregnancy has been described as a unique window of opportunity to positively 
influence the substance-using woman (Daley, Argeriou, & McCarty, 1998). The regular 
contact afforded by prenatal care allows providers an unparalleled chance to identify 
pregnant women who are using potentially harmful substances. Current obstetric practice 
guidelines recommend universal screening of pregnant women for past and present 
ATOD use to facilitate timely recognition during the critical stages of fetal development 
(American Academy of Pediatrics, 2002; American College of Obstetricians and 
Gynecologists, 2008; American Society of Addiction Medicine, 1989). However, 
prenatal care providers frequently fail to identify and intervene with substance-using 
patients (Chasnoff, Neuman, Thornton, & Callaghan, 2001). Deficient knowledge 
regarding treatment, lack of time, personal discomfort, and fear of acquiring a reputation 
that would deter patients have all been reported as reasons why practitioners fail to screen 
routinely for substance use by their pregnant patients (Zellman et al., 1999).  
Societal attitudes toward pregnant women who drink alcohol, smoke cigarettes or 
use drugs are negative, influenced by traditional beliefs about femininity and motherhood 
(Carter, 2002). Society’s stigmatic, punitive view of prenatal substance use contributes to 
the difficulties associated with the identification and treatment of this complex health 
disorder (Reis et al., 1992). Pregnant women are reluctant to disclose ATOD use, fearing 
negative responses such as distrust, labeling, disenfranchisement, incarceration, 
prosecution, and loss of custody (Jessup, Humphreys, Brindis, & Lee, 2003; Selleck & 
Redding, 1998; Tillett & Osborne, 2001). When prenatal ATOD use is identified, women 
frequently deny the need for assistance to reduce their use (Howell & Chasnoff, 1999). 
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Relatively few pregnant women accept referrals to substance use treatment and, among 
those who do, less than half follow through with the full course of treatment (Brady & 
Ashley, 2005).  
There is a critical need for effective interventions that can be promptly 
implemented in the primary prenatal care setting when a pregnant woman discloses 
potentially harmful substance use to a healthcare provider. Brief interventions are time-
limited, patient-focused, counseling strategies, implemented with the goal of motivating 
healthy decision-making, that have shown promise in the treatment of problem behaviors 
(Clay, 2010). Brief interventions are not only used for patients actively seeking treatment, 
but can occur opportunistically when health care providers become aware of problem 
behaviors during encounters that were initiated by patients for another reason (Moyer, 
Finney, Swearingen, & Vergun, 2002). Brief drinking-focused interventions have been 
used effectively during clinical encounters between health care providers and patients to 
motivate change (Bien, Miller, & Tonigan, 1993; Emmen, Schippers, Bleijenberg, & 
Wollersheim, 2004). Researchers have also reported success using this methodology in 
decreasing substance use during pregnancy (Armstrong et al., 2003; Chang et al., 2005; 
Ferreira-Borges, 2005; O'Connor & Whaley, 2007). Despite the reported success of these 
and similar studies, they lack key methodological ingredients that are critically needed to 
facilitate effective translation of a promising brief intervention from the research setting 
to the practice arena.  
Before a behavioral therapy can be generalized to clinical practice, it must 
meet the standards required of an empirically supported therapy by incorporating and 
reporting methodological aspects that make it reasonable to assume that the positive 
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effects observed were actually a result of the experimental treatment rather than from 
other confounding factors (Carroll & Rounsaville, 2007; Chambless & Hollon, 1998). 
This can be illustrated by comparing behavior therapy research to a controlled clinical 
trial conducted to investigate the effectiveness of a new drug. In addition to all of the 
procedural elements required of any randomized, controlled clinical trial, a drug clinical 
trial must stipulate specifics regarding the drug’s pharmacokinetics and the precise 
dosages used in the study. This same rigor is required of a clinical trial seeking to 
determine the efficacy of a behavioral intervention. The study must incorporate and 
provide precise information about the components of the treatment intervention that 
distinguishes it from other behavioral interventions, and provide methodological 
assurance that the treatment intervention was actually delivered.  
Monitoring and evaluating treatment fidelity, to determine if the intervention was 
delivered as intended, is an essential requirement of controlled therapeutic intervention 
research (Bellg et al., 2004). This imperative has become progressively evident as the 
literature increasingly abounds with reports of efficacious behavioral therapies that fail to 
be put into practice (Carroll & Rounsaville, 2007).  
Brief intervention implementation is a flexible, dynamic, individualized event, 
and these factors must be considered when designing fidelity assessment strategies. 
Measurement of treatment fidelity requires use of a research instrument that indexes the 
essential elements of an intervention and quantifies interventionist behaviors (Stein, 
Sargent, & Rafaels, 2007). Development of a treatment fidelity instrument entails 
operationalization of the treatment concepts and clinical protocol, guided by the theory 
on which the brief intervention is founded (C. F. Waltz, Strickland, & Lenz, 2005). 
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There are further considerations to be taken into account in the potential 
extrapolation of an efficacious intervention to the clinical practice setting. Most brief 
intervention studies that have been published to date have used specialists, such as 
physicians or therapists, in the role of interventionist. While such a design undoubtedly 
optimizes internal validity, it limits applicability to the real world of managed primary 
care where cost issues are a paramount consideration, and specialist time is a rare and 
expensive commodity ("Rising Costs Force," 2004; Wallace & Savitz, 2008). Primary 
care personnel with the earliest and most sustained contact with patients are frontline 
staff (Grumbach, Osmond, Vranizan, Jaffe, & Bindman, 1998). Frontline caregivers 
found in primary care offices or clinics are usually registered nurses, licensed vocational 
nurses, licensed practical nurses, and medical assistants (Chasnoff, McGourty, Wells, & 
McCurties, 2008; Grumbach & Bodenheimer, 2004). If potentially harmful substance use 
is disclosed to the caregiver, the apposite response is a brief opportunistic intervention 
(Chang, 2004), If potentially harmful substance use is disclosed to the caregiver, the 
apposite response is a brief opportunistic intervention  
Prenatal care providers in several areas of the United States (Alabama, Arkansas, 
California, Florida, Illinois, Indiana, Iowa, Kansas, Kentucky, New Jersey, New Mexico, 
Nevada, Oklahoma, Oregon, West Virginia, and the Commonwealth of Puerto Rico) use 
frontline staff to implement a particular brief opportunistic intervention for pregnant 
women who disclose current ATOD use (Chasnoff et al., 2008; Children's Research 
Triangle, 2008). This is the “I Am Concerned” (IAC) brief opportunistic intervention, 
which was specifically developed to address harmful prenatal substance use (Chasnoff & 
McGourty, 2003). 
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Awareness of IAC implementation by frontline staff, coupled with a lack of 
research demonstrating large-scale success with brief interventions in reducing ATOD 
use in pregnancy stimulated this proposal, which was born out of a desire to determine 
the efficacy of the IAC brief intervention when implemented by frontline staff. This study 
is the first step toward realizing this goal. There is a critical need for controlled clinical 
research that incorporates rigorous assessment of treatment fidelity to foster identification 
of evidence-based, efficacious interventions that help to reduce prenatal substance use. 
Such studies are necessary to promote effective translation from the research setting to 
primary care practice where the treatment can benefit childbearing women, their families, 
and society. 
Purpose of the Study 
The specific aims of this study were to: (a) develop an instrument that can be used 
accurately and reliably to measure the treatment fidelity with which the IAC brief 
opportunistic intervention is implemented; and (b) establish evidence of validity and 
reliability associated with the use of this instrument. 
The long-term goals of this line of research are to: (a) use this instrument to 
measure and ascertain the treatment fidelity with which frontline staff implement the IAC 
brief opportunistic intervention when it is delivered in a clinical setting for pregnant 
women who disclose ATOD use, (b) determine the efficacy of the IAC brief 
opportunistic intervention when implemented by frontline staff through randomized 
controlled study, and (c) disseminate the findings derived from this research to foster use 
of evidence-based interventions and reduce maternal ATOD use and adverse fetal 
consequences. 
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Research Questions 
This dissertation project answered the following questions: 
1. What is the content validity associated with an instrument developed to assess 
treatment fidelity in the delivery of a brief opportunistic intervention to 
decrease the use of alcohol, tobacco, and other drugs by pregnant women? 
2. What is the inter-rater reliability associated with use of an instrument 
developed to assess treatment fidelity in the delivery of a brief opportunistic 
intervention to decrease the use of alcohol, tobacco and other drugs by 
pregnant women? 
3. What is the internal consistency reliability associated with use of an 
instrument developed to assess treatment fidelity in the delivery of a brief 
opportunistic intervention to decrease the use of alcohol, tobacco, and other 
drugs by pregnant women? 
Operational Definitions of Study Terms 
Frontline staff members. These are primary health care personnel who interact 
with patients in advance of physicians or mid-level practitioners. The frontline staff 
members who work in prenatal offices or clinics are usually registered nurses, licensed 
vocational nurses, or medical assistants. 
Brief opportunistic intervention. A short, structured, behavioral treatment 
implemented by prenatal care providers when a clinical opportunity is presented to 
facilitate healthy decision-making on behalf of clients who are not specifically seeking 
treatment to reduce their ATOD use. 
 8 
Treatment fidelity. This is the degree to which the IAC brief opportunistic 
intervention is delivered as intended by the treatment protocol. The components of 
treatment fidelity are: (a) adherence, the extent to which the essential elements that 
distinguish the IAC brief opportunistic intervention have been implemented; and (b) 
competence, the quality of implementation and the skill with which frontline staff deliver 
the intervention and exhibit behaviors likely to engage and motivate clients. 
Prenatal substance use. Denotes any use of alcohol, tobacco, or illicit drugs, or 
misuse of prescription drugs during pregnancy.  
Standardized patient. Individual recruited and trained to act as a real patient to 
simulate a set of symptoms or problems. In this study, associate degree nursing students 
were the standardized patients. They portrayed ATOD-using pregnant women in a 
simulated clinical environment. 
Assumptions Underlying the Research 
This study rested on the following assumptions:  
1. Psychological traits and behaviors can be quantified and measured. 
2. It is possible to measure treatment fidelity in a simulated clinical situation. 
3. Independent raters listening to audio recordings of treatment sessions will be 
able to determine quantitative, objective measurements of treatment fidelity. 
Significance to Nursing  
Despite additional funding designated for the treatment of drug-addicted, 
childbearing women, little progress has been achieved with the national initiatives that 
have been implemented to discourage prenatal substance use (Substance Abuse and 
Mental Health Services Administration, 2008). National objectives regarding prenatal 
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substance exposure remain unrealized as abstinence rates associated with alcohol and 
other drugs have declined or remained the same (National Center for Health Statistics, 
1999). There is significant need for research to identify interventions that will decrease 
rates of ATOD use among childbearing women. This research endeavor was an initial 
step in addressing this need.  
Nursing researchers seek to provide evidence that supports the use of particular 
practices that are effective and efficient (Polit & Hungler, 1999). This study was 
premised on the staffing mix found in the primary health care environment and the reality 
of spiraling health care costs. Frontline staff members are cost-effective caregivers and, 
as such, they interface first and most frequently with patients. Prenatal care providers are 
using frontline prenatal clinic staff to implement the IAC brief opportunistic intervention 
for pregnant women who disclose current ATOD use (Chasnoff, Wells, McGourty, & 
Bailey, 2007). However, the quality of brief intervention implementation by this level of 
provider has yet to be determined. This study was a necessary first step toward 
determining the treatment fidelity with which frontline staff members implement brief 
opportunistic interventions in the primary clinic setting. In addition, the findings of this 
study will lay the foundation for a future randomized, controlled study measuring the 
efficacy of the IAC brief opportunistic intervention. 
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Chapter 2 
Review of Literature 
The continuing phenomenon of potentially harmful ATOD use during pregnancy 
has driven the quest for effective treatments (American College of Obstetricians and 
Gynecologists Committee on Ethics, 2004). Brief interventions using motivational 
interviewing techniques have shown promise in reducing prenatal substance use 
(Armstrong et al., 2003; Ferreira-Borges, 2005; Haug, Svikis, & DiClemente, 2004; 
O'Connor & Whaley, 2007). However, meaningful, replicable findings from randomized 
clinical trials exploring the efficacy of brief interventions are dependent on faithful 
delivery of the independent variable. A valid and reliable instrument enabling assessment 
and quantification of interventionist behaviors is necessary to establish treatment fidelity. 
The literature review for this research was organized around these elements and includes 
a summary of the research findings related to the harmful effects of prenatal ATOD 
exposure, brief intervention study findings and a comprehensive examination of the 
literature associated with treatment fidelity. I begin by describing the conceptual 
framework that provided the theoretical context for this study. 
Conceptual Framework 
 
This study was guided by concepts derived from motivational interviewing (MI), 
first described in 1983 when psychologist William R. Miller published an article 
explicating the innovative process he used to intervene with problem drinking. In the 
ensuing years, the concepts and approaches fundamental to MI have been further refined, 
elaborated and articulated (Miller & Rollnick, 1991, 2002), and MI’s theoretical 
framework has evolved through substantial testing (Miller & Rollnick, 2009). 
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Motivational interviewing. MI grew out of dissatisfaction with the 
confrontational, aggressive strategies that were widely advocated at the time for the 
treatment of addictive behaviors (Miller & Rollnick, 1991). Defined as a “client-centered, 
directive method for enhancing intrinsic motivation to change by exploring and resolving 
ambivalence” (Miller & Rollnick, 2002, p. 25), MI draws on constructs from several 
theoretical frameworks. The emphasis placed by client-centered theory on empathy as a 
critical condition of a therapeutic atmosphere (C. R. Rogers, 1956) was credited as 
providing significant inspiration during the development of MI. Maintaining a structured 
and directive therapeutic interaction within a collaborative environment is a hallmark of 
cognitive therapy (Beck, Wright, Newman, & Liese, 1993) that also became a central 
element of MI. Other theories that influenced the development of MI include cognitive 
dissonance theory (Festinger & Carlsmith, 1959), which posits that people are driven to 
reduce inner conflict created by discrepancies between their actions and their beliefs, and 
the theory of self-perception (Bem, 1967), which holds that people tend to develop 
attitudes by observing their behaviors, rather than the reverse. 
Miller and Rollnick (1991) aligned MI with key constructs of the trans-theoretical 
model of change (Prochaska & DiClemente, 1982). This model includes the hypothesis 
that individuals who are modifying behaviors move from a state of pre-contemplation, 
when no change is being considered, into a cyclical, multi-stage process that progresses 
through contemplation, determination, action, maintenance, and relapse. Prochaska and 
DiClemente’s inclusion of relapse as a normal, nonpathologic stage in the process of 
change was significant because it acknowledged that individuals often return to previous 
behaviors when attempting to change long-standing patterns. The original trans-
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theoretical model was conceptualized as a wheel of change, around which individuals 
typically circled several times before achieving stable behavior change (Prochaska & 
DiClemente, 1982), later revised to a spiral model, reflecting research findings that 
relapsing individuals typically reinitiate the process of change in the contemplation or 
preparation stages instead of regressing all the way back to the pre-contemplation stage 
(Prochaska, DiClemente, & Norcross, 1992). Initially, MI theory included a hypothesis 
that motivational approaches should differ in accordance with the location of the client in 
the change process, and specific therapeutic tasks targeted to each of the trans-theoretical 
stages were originally recommended to facilitate client progress toward sustained change. 
(Miller & Rollnick, 1991). However, this hypothesis was not supported by the findings of 
Project MATCH, a large clinical trial conducted to determine if patient-treatment 
matching improved outcomes for alcohol dependent individuals (Project MATCH 
Research Group, 1998).  
Principles of motivational interviewing. W. R. Miller and Rollnick (2002) 
identified four general principles involved in the application of MI. These are: expressing 
empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy.  
Empathy is defined as “the quality or process of entering fully, through 
imagination, into another’s feelings or motives” (Barnhart & Barnhart, 1984, p. 691). An 
empathetic counseling approach is not unique to MI, because many forms of Rogerian 
client-centered psychotherapy involve empathy on the part of the therapist to some 
degree. However, MI places particular emphasis on empathy, which is described as a 
“fundamental and defining characteristic” (Miller & Rollnick, 2002, p. 37). Expressing 
empathy involves perceiving the world from the perspective of the client through 
 13 
respectful, reflective listening (Miller & Rollnick, 1991, 2002). The therapeutic attitude 
that frames this principle is one of acceptance, a mind-set that denotes understanding 
rather than agreement or endorsement. This attitude of respect and acceptance is believed 
essential to the creation of a therapeutic alliance that will foster change. Observer ratings 
of therapist empathy were found to be predictive of positive therapeutic outcomes in a 
study conducted by W. R. Miller, Taylor, and West (1980) with problem drinkers, as well 
as in a large meta-analysis of empathy research (Bohart, Elliott, Greenberg, & Watson, 
2002). Another crucial aspect of this principle is recognition that client ambivalence is a 
normal component of change, and is to be expected rather than viewed as aberrant.  
The second principle of MI is intentional development of discrepancy, predicated 
on the hypothesis that people are motivated to change when they perceive inconsistencies 
between their behaviors and their core values (Miller & Rollnick, 1991, 2002). This 
directive approach is a departure from traditional client-centered counseling, which is 
non-directive and exploratory (C. R. Rogers, Kirschenbaum, & Henderson, 1989). MI 
involves facilitating clients’ awareness of the discrepancy between the way they want 
their life to be versus their current behavior through the use of techniques such as open-
ended questions, that elicit change talk (self-motivating speech) (Miller & Rollnick, 
2002). The therapist attempts to amplify the perception of discrepancy by reflecting, 
elaborating, and affirming the client’s change talk. A significant correlation was 
established between the frequency and strength of commitment language voiced by drug-
using clients during the final moments of MI therapy and their degree of abstinence at a 
1-year follow-up (Amrhein, Miller, Yahne, Palmer, & Fulcher, 2003). The therapeutic 
goal is to help the client develop awareness of discrepancy without feeling pressured or 
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coerced to do so. In keeping with this goal, a fundamental dynamic involved in 
developing discrepancy is that it is the client, not the therapist, who articulates the 
reasons for change. This accords with the finding that motivation tends to be enhanced 
when people hear themselves presenting arguments in support of change, as opposed to 
hearing them voiced by another (Bem, 1967). Although the mechanism by which MI 
triggers behavior change is unclear, the occurrence of increased commitment language 
may evidence a pivotal decision to engage in the process of change (Miller & Rose, 
2009).   
Because MI-guided therapists expect clients to be ambivalent regarding the 
importance of change, it follows that client reluctance to change will also be viewed as a 
normal, non-pathological part of the change process. This philosophy is manifested in the 
third general MI principle, rolling with resistance (Miller & Rollnick, 1991, 2002). Client 
resistance is not only expected, it is conceptualized as a treatment opportunity that can 
facilitate meaningful movement in the direction of change. Any resistance on the part of 
the client is met with therapist nonresistance, and argument is assiduously avoided. 
Clients’ feelings are respected and acknowledged through reflective responses, and 
resistant comments are viewed as an indication to respond differently or alter the 
approach. MI places clients, rather than therapists, in the role of the expert who must find 
solutions to the problems they have identified. In keeping with this overriding 
philosophy, client questions are typically reframed and directed back to the client.  A 
controlled comparison conducted with problem drinkers found a directive-confrontational 
counseling approach significantly predictive of increased frequency of client resistant 
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responses during therapy and their reported level of alcohol consumed at the 12-month 
follow-up (Miller, Benefield, & Tonigan, 1993).  
The fourth theoretical premise upon which MI is based is the concept of self-
efficacy (Miller & Rollnick, 1991, 2002). Self-efficacy, defined as an appraisal of one’s 
ability to carry out a specific task (Bandura, 2007), is a key predictor of an individual’s 
degree of perseverance (Bandura, 1977).  Support of client self-efficacy flows logically 
from previous MI principles; the assertion that the client has the sole responsibility to 
direct change implies that the client is perceived as capable of doing so (Miller & 
Rollnick, 1991, 2002). An intrinsic aspect of this principle is recognition that the 
therapist’s own belief in the client’s ability to accomplish meaningful change can work as 
a “self-fulfilling prophecy” (Miller & Rollnick, 2002, p. 41). The outcomes of individuals 
receiving treatment for alcoholism were significantly influenced in the direction of 
therapists’ expectancies (Leake & King, 1977; Parker, Winstead, & Willi, 1979). Viewed 
from an MI perspective, enhancing confidence is an attribute that is elicited, rather than 
imposed by the therapist, through interviewing techniques that include reframing, 
affirming previous successes, brainstorming, and providing information when appropriate 
within the context of the therapeutic interaction (Miller & Rollnick, 2002).  
Spirit of motivational interviewing. Miller and Rollnick (2002) emphasized that 
MI is more of “a way of being with people” (p. 34) than a set of techniques and cautioned 
that effective application of MI requires thoroughly understanding the spirit of MI. The 
components of the fundamental spirit of MI are (a) creating a collaborative and 
supportive atmosphere; (b) evoking motivation for change from within the client; and (c) 
affirming and respecting the client’s autonomy. Collectively, these overarching 
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characteristics generate the fundamental nature that appropriately occurs within the 
context of MI-guided therapy. 
The FRAMES model. Various modified approaches have been developed that 
integrate the spirit and principles of MI with non-motivational interviewing techniques 
(Miller & Rollnick, 2002); these have been termed “adaptations of motivational 
interviewing” (AMI) (Burke, Arkowitz, & Menchola, 2003).  Most studies testing the 
efficacy of MI have been found to involve AMIs (Burke et al.), rather than the pure 
clinical style described by Miller and Rollnick (1991, 2002). One such AMI is the 
FRAMES model, a brief intervention approach that has been widely adopted as a strategy 
to stimulate and support client behavior change (Miller & Rollnick, 1991). FRAMES 
provided inspiration to the authors of the IAC brief opportunistic intervention (Chasnoff 
& McGourty, 2003) that is at the core of this study. The acronym “FRAMES” represents 
the key elements embodied with this approach:  
1. Feedback is provided regarding the interventionist’s appraisal of the client’s 
current health status. 
2. Responsibility of the client for behavior change is explicitly emphasized. 
3. Advice is given unambiguously to make a change. 
4. Menu of strategies is provided that can assist the client to achieve change. 
5. Empathy forms the foundation of the interventionist’s interaction with the 
client. 
6.  Self-efficacy is fostered and reinforced by the interventionist. 
Numerous clinical trials have investigated the effectiveness of MI techniques in 
the treatment of addictive behaviors, and several meta-analyses have been carried out to 
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determine effect sizes across studies (Burke et al., 2003; Carey, Scott-Sheldon, Carey, & 
DeMartini, 2007; Hettema, Steele, & Miller, 2005; Rubak, Sandbaek, Lauritzen, & 
Christensen, 2005; Vasilaki, Hosier, & Cox, 2006). While MI counseling strategies were 
effective in the treatment of alcohol abuse (Burke et al., 2003; Carey et al., 2007; 
Hettema et al., 2005; Rubak et al., 2005; Vasilaki et al., 2006), and drug use (Burke et al., 
2003; Hettema et al., 2005), they did not result in significant reductions in smoking 
(Burke et al., 2003; Hettema et al., 2005; Rubak et al., 2005). MI was associated with 
larger effect sizes earlier in the course of addiction counseling in comparison with control 
or no treatment, which decreased over time as control group effect sizes effectively 
caught up with MI treatment groups (Hettema et al., 2005; Vasilaki et al., 2006). The 
positive effects of MI were more enduring when combined with other therapies and when 
introduced early in the treatment regimen (Hettema et al., 2005). MI was found to be 
more effective for both treatment-seeking and nontreatment-seeking individuals, although 
larger effect sizes were noted with treatment-seeking samples (Vasilaki et al., 2006). 
Motivational interviewing theory. Although substantial evidence exists to support 
the efficacy of MI-guided therapy, it has been criticized for lacking a sound theoretical 
base (Draycott & Dabbs, 1998). Self-determination theory (SDT), a conceptual model of 
motivation proposed by Deci and Ryan (2002), has been suggested as a useful framework 
with which to illuminate the basic theoretic assumptions that undergird MI (Foote et al., 
1999; Ginsburg, Mann, Rotgers, & Weekes, 2002; Markland, Ryan, Tobin, & Rollnick, 
2005; Vansteenkiste & Sheldon, 2006).  
Self-determination theory. SDT evolved from the study of intrinsic and extrinsic 
motivation; and describes the nature of human needs, the motives that drive need 
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fulfillment, and the environmental characteristics that affect human behavior (Deci & 
Ryan, 2002; Ryan & Deci, 2006). A basic tenet of SDT is the supposition that human 
beings have an instinctive inclination to develop an integrated self-image (Deci & Ryan, 
2002). This propensity to develop an inner sense of unity fosters the drive to establish 
constructive links among various facets of one’s own psyche as well as establish 
meaningful connections with other individuals.  
According to SDT, individuals have fundamental needs that must be satisfied to 
achieve psychological health (Deci & Ryan, 2000, 2002; Ryan & Deci, 2000). Needs are 
conceptualized as “innate psychological nutriments that are essential for ongoing 
psychological growth, integrity, and well-being” (Deci & Ryan, 2000, p. 229). The drive 
to meet these needs causes individuals to consciously or unconsciously seek situations 
that will allow them to be fulfilled (Deci & Ryan, 2002). Three universal needs are 
identified, the needs for autonomy, competence, and relatedness. 
1. Autonomous individuals perceive that their behavior is self-determined, rather 
than controlled by external forces.  
2. Individuals who have fulfilled their need for competence have a sense of 
confidence and effectiveness in relation to their interactions with their social 
environment and the expression of their capabilities.  
3. Satisfying the need for relatedness instills feelings of connectedness, 
belonging and genuine caring with others.  
Another fundamental concept of SDT is the distinction between causal variables 
that motivate an individual’s behaviors. SDT differentiates between behavior that is 
motivated autonomously and behavior motivated by a controlled orientation (Deci & 
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Ryan, 2002; Ryan & Connell, 1989). Behavior motivated by autonomous orientation 
occurs with volition from an internal impetus and is based one’s own interests. 
Conversely, controlled orientation refers to behavior that involves external regulation, 
such as through coercion from others, or self-edicts about how one should behave. These 
motivations are conceptualized as ordered along a “gradient of autonomy” (Ryan & 
Connell, 1989, p. 759) from internal to external causality. SDT theory includes the 
hypothesis that individuals will tend to gravitate toward autonomously motivated 
behaviors when their innate needs for competence, relatedness, and autonomy have been 
met (Deci & Ryan, 2002; Ryan & Connell, 1989). 
According to SDT, individuals are intrinsically motivated to self-regulate and 
become increasingly autonomous through a process called internalization. (Deci & Ryan, 
2002; Ryan & Connell, 1989). Internalization involves the assimilation of externally 
regulated values into internally regulated values. Two forms of internalization are 
recognized by SDT, introjection and integration. Introjection is a suboptimal type of 
internalization that occurs when an externally regulated value is partially taken in without 
full acceptance as one’s own. Integration involves more extensive internalization that 
takes place when individuals fully assimilate an externally regulated value, synthesizing 
the behavior with their core sense of self and accepting it as their own. 
Motivational interviewing and self-determination theory. The basic premises 
of SDT mesh conceptually with the elements that shape MI and provide a theoretical 
basis for interpreting the efficacy of MI (Foote et al., 1999; Ginsburg et al., 2002; 
Markland et al., 2005; Vansteenkiste & Sheldon, 2006). Both frameworks are based on 
the fundamental assumption that individuals are inherently inclined toward positive 
 20 
change (Markland et al.; Vansteenkiste & Sheldon). Described by Deci and Ryan (2002) 
as “natural, innate, and constructive tendencies to develop an ever more elaborated and 
unified sense of self” (p. 5), this concept was characterized by Miller and Rollnick (2002) 
as “a natural process of change” (p. 4).  These beliefs support the approach to counseling 
that is endorsed by both SDT and MI, that the therapist’s role is to elicit the client’s 
inherent motivation, rather than attempt to establish a process of change. STD defines 
this concept as assisting “autonomous motivation for specific health care or educational 
behaviors” (p. 239).   
Markland and colleagues (2005) aligned the construct of universal needs specified 
within the SDT framework to MI principles and techniques, and, although not explicitly 
stated, the FRAMES strategies of  giving advice and providing feedback. The MI-guided 
interventionist supports clients in meeting each of the SDT basic needs as follows: 
1. Competence: present clear and neutral information about behavior and 
outcomes, help the client develop appropriate goals, provide positive 
feedback, and support self-efficacy.   
2. Autonomy: avoid coercion, roll with resistance, explore options, encourage 
change talk, and let the client make decisions about what and how to change. 
3. Relatedness: express empathy, explore client’s concerns, demonstrate 
understanding of the client's position, and avoid judgment or blame (p. 821).  
 Seen through the conceptual lens of SDT, MI therapeutic outcomes can be 
construed as associated with fulfillment of basic needs (Markland et al., 2005; 
Vansteenkiste & Sheldon, 2006). Placing key MI elements within the conceptual 
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boundaries of SDT creates a theoretic bridge between MI and behavior change and 
affords researchers a means of gaining deeper insight into the way that MI works. 
Summary. The focus of this study was development of a research instrument 
capable of valid and reliable measurement of the fidelity with which the IAC brief 
opportunistic intervention is implemented. This process required operationalization of 
complex variables, reducing them from abstract concepts to observable indicators. The 
likelihood that the resulting tool reflected the phenomenon of interest was enhanced 
through the use of a guiding conceptual framework (C. F. Waltz et al., 2005). MI 
principles and techniques, instrumental in the development of the IAC, are theoretically 
strengthened when bolstered by SDT constructs. The union of these two models provided 
a core ideology that was used to guide the conceptual translation of key principles 
involved in IAC implementation. 
Prenatal Substance Exposure 
Alcohol, tobacco, marijuana, cocaine, opioids, and amphetamines are the drugs 
most commonly used by pregnant women (Shiono, 1996; Suellentrop, Morrow, Williams, 
& D'Angelo, 2006; Vega et al., 1993) and poly-drug use patterns are pervasive (Chasnoff 
et al., 2008; Lester, Andreozzi, & Appiah, 2004; Lester et al., 2001; Wolfe, Davis, 
Guydish, & Delucchi, 2005). Although public concern has been primarily focused on 
illicit substances, use of legally obtained alcohol and tobacco is far more prevalent during 
pregnancy. Researchers conducting a landmark prenatal substance exposure study in 
1992, analyzed data obtained through urine toxicology screening and self-reported 
tobacco use from 29,494 pregnant women presenting for delivery in California hospitals 
(Vega et al.). Specific drug prevalence rates were: tobacco, 8.82%; alcohol, 6.72%; 
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marijuana, 1.88%; opioids, 1.47%; cocaine, 1.11%; amphetamines, 0.66%. Overall, 
5.16% of the women screens were positive for one or more illicit drugs. The 
predominance of alcohol and tobacco use is corroborated by national prevalence data 
from the National Household Survey on Drug Abuse (Substance Abuse and Mental 
Health Services Administration, 2010). Estimated rates of use from the 2009 survey (the 
most recent year available for study) of pregnant women aged 15 to 44 years were: 
tobacco, 15.3%; alcohol, 10.0%; and illicit drug use, 4.5% (individual illicit drug 
prevalence rates were not provided). 
Prenatal alcohol use. Alcohol is a widely recognized human teratogen and the 
negative effect on fetuses of mothers who consume alcohol has been well established. 
Fetal alcohol exposure is a principal cause of birth defects, mental retardation, and 
neurodevelopmental disorders, sequelae that are entirely preventable (Barr & Streissguth, 
2001; Goodlett, Horn, & Zhou, 2005; Lester, Tronick et al., 2004; Meschke, Holl, & 
Messelt, 2003). During pregnancy, there is no amount of alcohol that can be safely 
consumed, nor any period of time that is considered safe to drink (Barr & Streissguth, 
2001). Alcohol crosses the placental barrier and enters fetal circulation rapidly after 
maternal ingestion (Streissguth & Finnegan, 1996). Analysis of the placental transfer 
properties of alcohol reveals that it diffuses freely across the placental membrane, 
resulting in fetal serum concentrations that equal or exceed maternal serum levels (Little 
& VanBeveren, 1996). Alcohol is eliminated more slowly from amniotic fluid than from 
maternal circulation, remaining in fetal circulation when it is no longer present in 
maternal serum (Tranmer, 1985). 
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Prenatal tobacco use. There is considerable evidence regarding the fetal harm 
caused by prenatal exposure to tobacco, adverse impacts that extend into the postnatal 
period. Although there has been a concerted effort to increase awareness regarding the 
risks associated with smoking during pregnancy, prenatal tobacco use remains a 
significant public health concern (Centers for Disease Control and Prevention, 2000). 
Cigarette smoke is a complex substance composed of more than 4,000 compounds; some 
originate in the tobacco itself and others are created when the tobacco is burned (Lester, 
Andreozzi et al., 2004; Talbot, 2008). Harmful effects associated with intrauterine 
tobacco exposure are thought to be primarily due to chemically mediated interference 
with reproductive organ function and the teratogenic aspects of nicotine (Greene & 
Goodman, 2003; Lester, Andreozzi et al.; Medoff-Cooper & Verklan, 1992; Miles, 
Lanni, Jansson, & Svikis, 2006) 
Prenatal opiod use. Opioid describes any drug that attaches to opiate receptors in 
the central nervous system (Deglin & Vallerand, 2009). This class of drugs includes 
morphine (a naturally occurring opioid), heroin (semi-synthetic), and methadone 
(synthetic); all of these produce nearly identical effects (U.S. Drug Enforcement 
Administration, 2009). A rapid rate of opioid placental transfer has been demonstrated 
directly using animal models (Ruckebusch, Gaujoux, & Eghbali, 1976) and indirectly by 
acute signs of withdrawal exhibited by opioid-exposed neonates following delivery 
(Greene & Goodman, 2003). Neonatal abstinence syndrome is marked by behavioral and 
physiologic indicators that include irritability, hypertonia, diarrhea, vomiting, and poor 
feeding (Curet & Hsi, 2002; Johnson, 2001; Kenner, Dreyer, & Amlung, 2000; Oei & 
Lui, 2007).  
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Prenatal cocaine use. Cocaine’s vasoconstrictive properties have been suggested 
as the mechanism underlying the damage associated with prenatal use (Holzman & 
Paneth, 1994; Plessinger & Woods, 1993, 1998). Uterine arterial vasoconstriction 
induced by maternal cocaine use is associated with impaired placental perfusion and 
subsequent fetal hypoxemia (Woods, Plessinger, & Clark, 1987). An in vitro placental 
perfusion study found that cocaine interfered with amino acid transport across the 
placenta, a phenomenon that may further contribute to the fetal harm associated with 
prenatal use of cocaine (Pastrakuljic, Derewlany, Knie, & Koren, 2000).  
Prenatal amphetamine use. Amphetamine mixtures comprise a group of central 
nervous stimulants, including amphetamine, methamphetamine, and dextroamphetamine, 
with very similar properties and actions (National Institute on Drug Abuse, 2009). These 
drugs induce synaptic release of catecholamines, producing numerous pharmacological 
effects that include vasoconstriction, insomnia, and anorexia (Deglin & Vallerand, 2009). 
The maternal and fetal effects of amphetamine, while similar to those produced by 
cocaine, are not identical (Plessinger, 1998). Animal research has demonstrated the 
facility with which amphetamine compounds cross into the fetal compartment, resulting 
in peak fetal concentrations that ultimately exceed maternal serum levels due to the 
slower rate of fetal elimination (Burchfield, Lucas, Abrams, Miller, & DeVane, 1991).  
Fetal damage associated with prenatal amphetamine exposure may occur directly through 
placental transfer or indirectly as a result of vasoconstrictive and sympathomimetic 
effects on the mother (Wouldes, LaGasse, Sheridan, & Lester, 2004). Neonatal 
abstinence syndrome that has been observed by some researchers studying amphetamine- 
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exposed newborns (Oei & Lui, 2007; Smith et al., 2003) has not been observed in others 
(Ludlow, Evans, & Hulse, 2004).   
Brief Interventions 
Brief intervention has been characterized as a short, dynamic form of 
psychotherapy (Borden, 1999) delivered by trained individuals with the goal of assisting 
clients with problems of living (Gurman & Messer, 2005). Brief intervention is a type of 
treatment modality that refers to multiple therapeutic techniques of varying lengths, used 
with diverse groups, in assorted settings (Bien et al., 1993; Miller & Wilbourne, 2001; 
Moyer et al., 2002; Tevyaw & Monti, 2004). Therapeutic components of brief 
interventions may include: motivational interviewing, advice, education, counseling, 
feedback, behavior contracting, or self-control training (Miller & Wilbourne, 2001). 
Although brief interventions are, by definition, shorter in duration than more extensive 
traditional behavioral therapy, there is wide variation in the length of treatments given 
this designation. Brief interventions can be delivered opportunistically in a primary care 
setting as a single 5- to 10-minute event for nontreatment-seeking individuals, or 
conducted by a therapist over three to four sessions for individuals seeking treatment for 
specific problem behaviors (Moyer et al., 2002). Despite this wide variation, brief 
interventions have been found effective in reducing the incidence of harmful alcohol use 
with a variety of populations across a wide range of settings (Bien et al., 1993; Kaner et 
al., 2007; Miller & Wilbourne, 2001; Moyer et al., 2002; Perl, 2001; Vasilaki et al., 2006; 
Wilk, Jensen, & Havighurst, 1997). 
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Brief intervention efficacy in the general population. Researchers have 
measured the impact of brief interventions on alcohol consumption among the general 
populations. Meta-analyses of findings of similar studies showed a significant benefit 
associated with brief interventions; all reported small to medium aggregate effect sizes in 
support of brief intervention groups as compared to control groups (Kaner et al., 2007; 
Moyer et al., 2002; Vasilaki et al., 2006; Wilk et al., 1997). Brief interventions were more 
effective with heavier drinkers (Kaner et al., 2007; Vasilaki et al., 2006; Wilk et al., 
1997), a finding not supported in the study by Moyer and colleagues (2002), who found 
larger effect sizes when heavy drinkers were removed from the analysis. Treatment-
seeking patients received greater benefit from brief intervention (Moyer et al., 2002) or 
no significant difference in effect (Vasilaki et al., 2006) compared to nontreatment-
seekers. One study found greater effect sizes among men as compared to women (Kaner 
et al., 2007), a finding that was not corroborated in other reviews (Moyer et al., 2002; 
Vasilaki et al., 2006; Wilk et al., 1997). Aspects of time were considered in some of the 
analyses. While Wilk et al., (1997) found that effect size increased with more than one 
session, no significant difference in effect size was associated with the length of the brief 
intervention (Kaner et al., 2007; Moyer et al., 2002; Wilk et al., 1997). Effect sizes were 
largest at earlier follow-ups and tended to degrade over time and  (Moyer et al., 2002; 
Vasilaki et al., 2006). 
These studies provide support for the role of brief interventions in reducing 
harmful drinking among heavy drinkers in the general population. They also highlight the 
value that a preponderance of controlled studies plays in demonstrating relationships and 
causality. 
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Brief interventions with pregnant women. Brief interventions have been 
reported to benefit pregnant, substance-using women (Armstrong et al., 2003; G. Chang 
et al., 2005; Ferreira-Borges, 2005; O'Connor & Whaley, 2007). The American College 
of Obstetricians and Gynecologists (2008)  recommends universal ATOD screening 
followed by brief interventions and appropriate referrals for ATOD-positive pregnant 
women. 
Four randomized controlled studies analyzed the impact of brief interventions on 
prenatal alcohol consumption. Pregnant women identified at risk for prenatal alcohol 
intake were randomized to experimental groups receiving brief educational interventions 
(Chang et al., 2005; Chang, Wilkins-Haug, Berman, & Goetz, 1999; O'Connor & 
Whaley, 2007) or motivational interviews (Handmaker, Miller, & Manicke, 1999). 
O’Connor and Whaley (2007) reported a 5-fold increase in days of abstinence among 
women in the brief intervention group (F[1.241] = 4.33, p < .04). G. Chang and 
colleagues (2005) found that an already significant reduction in prenatal alcohol 
consumption in the treatment group (b = - 0.163, SE [b] = 0.063, p < .01) was magnified 
when the woman’s partner was present for the intervention (b = - 0.932, SE [b] = 0.468, p 
< .05). In the other two studies, the difference in alcohol intake between control and 
intervention groups did not reach statistical significance (Chang et al., 1999; Handmaker 
et al., 1999). 
Neonatal measures have been analyzed to assess the effect of brief interventions 
given to substance-using pregnant women (Armstrong et al., 2003; O'Connor & Whaley, 
2007). Researchers compared the fetal mortality rate of two groups of pregnant women 
participating in the Supplemental Nutrition Program for Women, Infants, and Children 
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(WIC) who had alcohol-positive screening results (O'Connor & Whaley, 2007). Infants 
born to women who had received a 15-minute brief intervention from WIC nutritionists 
were heavier (F [1.194] = 3.59, p < .06), and longer (F [1.194] = 4.48, p < .03) at birth in 
comparison to the infants born to the women in the control group who received 
assessment and advice to stop drinking. Other investigators compared neonatal outcomes 
of infants born to ATOD-positive pregnant women who (a) received a screening only, (b) 
received a screening and an assessment, or (c) received screening, assessment, and a brief 
intervention, with a control group of women who had screened negative for ATOD use 
(Armstrong et al.). Chi-square analysis revealed no significant difference in the incidence 
of preterm delivery, birth weight, or assisted ventilation rate between the brief 
intervention and control groups (all p values > 0.17). Conversely, significant differences 
were noted on all three outcomes for the other two groups of ATOD-using women in 
comparison to the control (all p values < 0.0024).  
The effectiveness of brief interventions among pregnant tobacco smokers has 
been studied. Ferreira-Borges (2005) found that women in the brief intervention 
experimental group had significantly higher levels of tobacco abstinence at a 2-month 
follow-up assessment compared to the women in the control group (x
2
 = 4.93, p = 0.02). 
In another randomized controlled trial with methadone-maintained, nicotine-dependent 
pregnant women, no significant difference in reduction of tobacco use between the brief 
intervention and control groups was observed (Haug et al., 2004). The complex 
psychosocial issues associated with opioid-dependent pregnant women limit the 
generalizability of these findings. 
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Although there have been relatively few studies conducted with pregnant women, 
brief interventions have demonstrated some effectiveness in reducing prenatal substance 
use and exerting a beneficial impact on neonatal outcomes. Further controlled research 
incorporating assessment of treatment fidelity is needed to determine the effectiveness of 
specific brief interventions and to facilitate replication in the primary care prenatal 
setting.  
Non-specialist brief intervention implementation. Another promising avenue of 
study is determining the relative effectiveness of brief intervention by non-specialists. 
Although most brief intervention research has used physicians or research staff to 
implement the interventions, there are a few studies that have examined this treatment 
modality with non-specialists.  
Investigators compared the provider-specific frequency of brief intervention 
implementation for patients who screened positive for harmful levels of alcohol use by 
two levels of providers in a multi-site study (Babor, Higgins-Biddle, Dauser, Higgins, & 
Burleson, 2005). Under one study condition, medical providers (physicians, physician 
assistants or nurse practitioners) delivered the brief interventions. In the other condition, 
brief interventions were implemented by mid-level professionals (nurses or health 
educators). Researchers found that mid-level professionals screened a higher percentage 
of patients than medical providers (24% and 19% respectively) and, among those patients 
screening positive, more patients in the mid-level condition received a brief intervention 
(73.1% versus 57.1%). This study focused solely on the frequency of implementation and 
did not measure comparative alcohol intake reduction. 
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Gamma-glutamyl transferase (GGT), a liver function test capable of detecting 
chronic alcohol intake (Pagana & Pagana, 2009), was the pre-treatment and post-
treatment measurement used to determine the effectiveness of a brief intervention 
delivered by a nurse to patients identified as heavy drinkers (Tomson, Romelsjo, & 
Aberg, 1998). The mean GGT values (measured in microkatals per liter) in the nurse-
interventionist treatment group had decreased significantly from 1.52 at baseline to 1.21 
at the 2-year follow-up (p = 0.02), while the GGT values of the control group receiving 
traditional physician advice increased from 1.74 to 2.16 (p = 0.34).   
In the study conducted by O’Connor and Whaley (2006), WIC nutritionists 
implemented brief interventions for pregnant women. This is the only prenatal study that 
has used nonmedically trained health professionals as interventionists. To date, no studies 
have been published measuring the effectiveness of brief interventions conducted by 
frontline staff in reducing ATOD use during pregnancy. 
Brief intervention cost-effectiveness. Fleming and colleagues (2002) estimated 
economic costs and benefits associated with physician-conducted brief interventions for 
the treatment of problem drinking. A randomized, controlled clinical trial was performed 
to evaluate the long-term effectiveness of a brief intervention delivered to patients who 
screened positive for at-risk drinking. The trial found sustained reductions in alcohol use 
in the treatment group over the 48-month follow-up period. These researchers also 
performed a complex benefit cost analysis that estimated a net benefit of $7,780 per 
patient receiving the brief intervention. The calculated differential in cost savings 
between the two groups was derived from medical care savings (emergency department 
visits and hospitalizations), avoidance of legal events (e.g., arrests for assault, abuse, 
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theft, disorderly conduct, property damage), and motor vehicle events (driving under the 
influence, crashes, and fatalities). The results of this study provide compelling evidence 
in support of using brief interventions to treat problem drinking in terms of cost as well as 
efficacy. 
Treatment Fidelity 
In the 1950s, as new schools of psychoanalytic thought arose and the incidence of 
comparative behavioral therapy outcome research increased, the scientific community 
began to voice concerns regarding the reported effectiveness of psychotherapeutic 
interventions (Luborsky, Singer, & Luborsky, 1975). This literature review section 
presents a chronology of the development of treatment fidelity, which emerged as a 
methodological strategy to address these concerns. Significant procedural aspects 
associated with the assessment of treatment fidelity will also be explored.  
History of treatment fidelity. Eysenck (1952) challenged hypotheses that 
psychotherapy facilitated recovery from neuroses. He summarized the results of 
descriptive studies that reported improvement of neurotic patients after psychotherapy 
and compared these findings using statistics derived from hospital records and disability 
claims to estimate percentages of similar patients who recovered without benefit of 
psychotherapy. He deduced an aggregate recovery rate of 72% for patients receiving no 
psychotherapy (under the care of a general practitioner or in custodial treatment), while 
only 66% of patients receiving psychotherapeutic treatment recovered. Eysenck 
acknowledged the shortcomings of his actuarial comparison but nevertheless concluded 
that his findings raised serious concerns regarding the results of studies reporting 
favorable effects of psychotherapy. His recommendation for further “carefully planned 
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and methodologically more adequate” (p. 323) experimental research to provide reliable 
evidence regarding the efficacy of psychotherapy was an early harbinger of the scientific 
community’s recognition of the importance of identifying research strategies assuring 
accurate, faithful treatment delivery.  
A comprehensive evaluation of controlled comparative treatment research, a field 
of study that began in the middle 1950s, reported that the studies reviewed rarely offered 
evidence that the delivered treatment actually corresponded to the intended treatment 
(Luborsky et al., 1975).  Insignificant differences were noted between psychotherapeutic 
models in terms of their demonstrated effectiveness, leading investigators to conclude 
that patients tend to benefit from any therapy that involves a helping relationship with a 
therapist. 
The concept of fidelity, introduced in 1981, was defined as the faithfulness with 
which researchers and clinicians implemented behavioral treatments (Yeaton & Sechrest, 
1981). The authors coined the terms “treatment strength” to refer to the “ a priori 
likelihood that the treatment could have its intended outcome” (p. 156) and “treatment 
integrity” as “the degree to which treatment is delivered as intended,” (p. 160) and argued 
that any determination regarding the appropriateness of a treatment should only be made 
after attending closely to both strength and integrity.  
A review of applied behavioral research literature published between 1968 and 
1980, reported that, although articles consistently contained reliability estimates of the 
dependent variable, 80% failed to report adequate efforts to ensure integrity of the 
independent variable (Peterson, Homer, & Wonderlich, 1982). The lack of 
methodological rigor created doubt about the quality of data and conclusions resulting 
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from these studies, and recommendations included intensive interventionist training and 
incorporation of a method to measure the accuracy of treatment delivery to ensure 
accurate application of the independent variable.   
A “technology model” of research design and implementation proposed using the 
same precision and rigorous methodology applied to pharmacology trials when carrying 
out behavioral therapy research (Carroll & Rounsaville, 1990). To protect the 
independent variable and enhance internal validity, this approach specified manual-
guided treatment, thorough operationalization of treatment delivery, interventionist 
training, and ongoing supervision of treatment implementation.  
The term “treatment fidelity” was first introduced in a survey of psychosocial 
therapy outcome literature culled from major journals published between 1980 and 1988 
(Moncher & Prinz, 1991) Among the 359 treatment outcome studies evaluated, over half 
made no mention of design methods to address treatment fidelity. 
A review of prevention program outcome evaluation literature was conducted to 
determine the degree to which the programs were implemented as planned (Dane & 
Schneider, 1998). When behavioral intervention studies published between 1980 and 
1994 were examined, investigators found that only 24% of the programs incorporated 
procedures to verify program integrity. In addition, they noted that, although the major 
journals containing most of the studies included in the sample stipulated inclusion of 
program integrity strategies as a prerequisite of publication acceptance, these 
requirements appeared to have been loosely enforced.   
Rounsaville, Carroll, and Onken (2001) discussed the evolution of treatment 
efficacy research and the mandate placed on investigators to develop treatment manuals 
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and valid methods of evaluating treatment fidelity in order to qualify for government-
funded research support. They reported that, due to the considerable effort involved in 
addressing treatment fidelity in advance of conducting randomized clinical trials, the 
National Institute on Drug Abuse had developed the “Stage Model of Behavioral 
Therapies Research.” The model demarcates three distinct stages of research and 
advocates research-funding support at each level to encourage development and testing of 
innovative therapies. Appropriate stage-one research activities include the development 
of programs, manuals, training, fidelity measures, and pilot testing. 
A meta-analysis of the treatment fidelity practices reported in health behavior 
change outcome literature between 1990 and 2000 reported no significant increase in the 
frequency with which researchers addressed the issue of treatment fidelity (Borrelli et al., 
2005). Of the articles analyzed, 54% failed to identify inclusion of strategies necessary to 
monitor the reliability and validity of behavioral interventions.  
A review of randomized controlled trials testing the efficacy of psychotherapeutic 
interventions was published between 2000 and 2004 (Perepletchikova, Treat, & Kazdin, 
2007). Investigators found that, although the evaluative measures used to determine 
adequacy were consistent with those recommended in the literature, only 3.5% of the 
studies reported implementation of adequate treatment fidelity procedures. They also 
noted that researchers consistently devoted greater attention to reliability and operational 
definitions of behaviors serving as outcome measures, than to those associated with the 
independent variable, echoing an observation made 25 years earlier (Peterson et al., 
1982). 
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Rationale for assessing treatment fidelity. Strategies allowing assessment of 
treatment fidelity are requisite components of submissions for government grant funds 
and referred journal publications. Nevertheless, most of the investigators who have 
conducted comparative psychotherapy research have failed to address treatment fidelity 
despite the increasing emphasis placed upon this by the scientific community. Rationale 
articulated in the literature regarding the importance of incorporating treatment fidelity 
processes in psychotherapy research include considerations involving external validity, 
internal validity, statistical analyses, interventionist training, and feasibility of treatment.  
External validity. Research is generally not conducted solely to discover 
relationships among variables for the individuals participating in the study, but also to 
reach conclusions that can benefit populations extending beyond the study sample (Polit 
& Hungler, 1999). External validity refers to generalizability, or the degree to which the 
results of the study would hold with other populations, in other places, and with 
alternative measurement instruments (Campbell & Stanley, 1966). Research results that 
can be generalized to other settings and samples are said to have a high degree of external 
validity (Campbell & Stanley, 1966).  
A relevant aspect of external validity in relation to treatment fidelity pertains to 
the focus on translation of research findings into practice settings. There are advantages 
in a study that provides unambiguous treatment guidelines and clear documentation of the 
procedures used to assess the quality of implementation. When a study incorporating 
these procedures reports that an effective treatment was implemented with high fidelity, 
the opportunity for dissemination of effective treatments across the research-practice gap 
is increased (Bellg et al., 2004; Dumas, Lynch, Laughlin, Smith, & Prinz, 2001; Spillane 
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et al., 2007). 
Treatment fidelity is critical to the maintenance of external validity in controlled 
psychotherapy research. The processes involved in treatment fidelity assessment require 
clear identification of treatment content; this is also necessary for replication of results 
(Moncher & Prinz, 1991). Use of a treatment manual has been identified as essential to 
the conduct of behavioral treatments in clinical trials to standardize interventionist 
training, and to reduce implementation variance (Rounsaville et al., 2001). A review of 
health behavior change outcome studies published between 1990 and 2000 noted that 
35% reported use of a treatment manual (Borrelli et al., 2005); a similar review of studies 
published between 2000 and 2004 found that 65% reported use of a specific treatment 
protocol (Perepletchikova et al., 2007). This change in the frequency of use of treatment 
manuals is significant and may herald a trend.  
Use of a treatment manual alone is insufficient to protect against threats to 
external validity. While a detailed description of proper implementation is necessary, it is 
also necessary to assess, verify, and document the quality of treatment implementation 
(Dumas et al., 2001; Peterson et al., 1982). These activities comprise the core of 
treatment fidelity and must be built into study methodology before a legitimate evaluation 
of treatment efficacy can occur.  
Internal validity. When the goal of research is to establish a causal relationship, 
internal validity is a primary consideration (Trochim & Donnelly, 2007). Internal validity 
refers to the degree that it is possible to infer that the effect on the dependent variable was 
actually produced by the independent variable rather than resulting from extraneous 
variables (Campbell & Stanley, 1966). Faithful delivery of the independent variable is a 
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hallmark of controlled research. When the independent variable takes the form of a drug 
in a randomized controlled trial, it may be sufficient to simply report the dosage and route 
of administration. However, when a randomized controlled trial is conducted to compare 
the efficacy of psychotherapeutic treatment with an alternative control treatment, it is 
insufficient to simply state in the method section that a given treatment was implemented 
(Peterson et al., 1982). The implementation of a complex behavioral treatment by an 
interventionist is much less straightforward, and a fair comparison to the control depends 
on methodological assurances that the intended treatment was actually delivered as 
designed (Luborsky et al., 1975; Moncher & Prinz, 1991; Peterson et al., 1982).  
Compromises to internal validity may result from inaccurate interventionist 
implementation such as the omission of prescribed treatment components or the addition 
of proscribed components (Borrelli et al., 2005; Moncher & Prinz, 1991; Perepletchikova 
et al., 2007). Thus, significant results could actually be due to an effective treatment or a 
Type I error that occurred because unintended ingredients were added to the intervention. 
Conversely, insignificant results could be the result of a weak treatment or a Type II error 
due to inadequate administration of the intervention (Borrelli et al., 2005; Moncher & 
Prinz, 1991; Perepletchikova et al., 2007; Polit & Hungler, 1999). Regardless of whether 
research findings note a large treatment effect or lack of effect, failure to address 
treatment fidelity issues erodes confidence in the study outcomes (Bellg et al., 2004; 
Borrelli et al., 2005; Luborsky et al., 1975; Moncher & Prinz, 1991; Perepletchikova et 
al., 2007; Peterson et al., 1982).  
Statistical analysis. Attention to treatment fidelity improves statistical power by 
reducing unintended variability in treatment effect due to uneven delivery by 
 38 
interventionists (Dumas et al., 2001; Yeaton & Sechrest, 1981). Because sample size is 
another invariant factor in the calculation of statistical power, attention to treatment 
fidelity may reduce study costs. As power increases, a proportionately smaller sample 
size can be used in a test of statistical significance (Bellg et al., 2004; J. Cohen, 1977; 
Resnick et al., 2005).  
Rather than an all-or-none occurrence, treatment fidelity is a phenomenon that can 
be conceptualized as falling along a continuum measuring the extent of intervention 
exposure (Moncher & Prinz, 1991). This operationalization allows treatment fidelity to 
be used as a direct factor in statistical analyses. If fidelity assessment involves measuring 
the degree of intervention actually received, this “intervention dosage” can be inserted as 
an independent variable into a regression analysis (Sidani, 1998).  
Treatment fidelity measures can be quantified and used in data analyses to 
determine degrees to which results are due to study intervention. In a longitudinal, multi-
site study measuring the effectiveness of a cognitive-behavioral approach to substance 
abuse prevention, researchers identified a direct relationship between the extent of 
program implementation and outcomes (Botvin, Baker, Dusenbury, & Tortu, 1990). They 
found that participants receiving a higher intervention dose had correspondingly lower 
levels of substance use than individuals receiving a lower dose. 
Interventionist training and performance. Results of fidelity assessment can be 
used as a feedback mechanism to enhance interventionist training and performance (J. 
Waltz, Addis, Koerner, & Jacobson, 1993). Evaluation of treatment fidelity illuminates 
lapses in implementation and facilitates identification of interventionists in need of 
training augmentation (Carroll, Nich, & Rounsaville, 1998; Resnick et al., 2005; J. Waltz 
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et al., 1993). Additionally, treatment fidelity assessment tends to encourage optimal 
adherence to the treatment protocol by interventionists (Borrelli et al., 2005).  
Treatment feasibility. Assessment of treatment fidelity provides information 
about the feasibility of implementing a treatment protocol in practice (Dusenbury, 
Brannigan, Falco, & Hansen, 2003). If treatment interventions were difficult to 
implement with adequate fidelity, steps can be taken to redesign the protocol to enhance 
outcomes.  
Components of treatment fidelity. Also referred to as treatment integrity (Dane 
& Schneider, 1998; J. Waltz et al., 1993; Yeaton & Sechrest, 1981), fidelity of 
implementation (Dusenbury et al., 2003), and intervention fidelity (Santacroce, 
Maccarelli, & Grey, 2004), Treatment fidelity is a relatively nascent concept described in 
the literature (Dusenbury et al., 2003). There is general agreement that adherence and 
competence are the key elements of treatment fidelity.    
Adherence. Adherence is a component of treatment fidelity that describes the 
degree to which the essential processes associated with the treatment protocol are 
implemented and prohibited elements are avoided (Dane & Schneider, 1998; Dusenbury 
et al., 2003; Moncher & Prinz, 1991; Santacroce et al., 2004; Stein et al., 2007). 
Measurement of adherence requires operationalization of the unique elements that 
distinguish a particular treatment protocol to determine the extent to which the guidelines 
are followed during implementation (Carroll et al., 2000; Mowbray, Holter, Teague, & 
Bybee, 2003).  
Competence. The second major aspect of treatment fidelity is competence, which 
is the level of interventionist skill during implementation or quality of treatment (Barber, 
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Liese, & Abrams, 2003; Hogue, Liddle, & Rowe, 1996; J. Waltz et al., 1993). 
Measurement of competence involves operationalization of treatment elements that 
distinguish the manner in which the interventionist delivers the treatment and may 
include contextual behaviors such as communication of empathy, collaboration, 
responsiveness, and sensitivity (Hogue et al., 1996; J. Waltz et al., 1993). Indicators of 
competence should be theoretically derived from the specific treatment protocol rather 
than from general concepts of therapeutic behaviors (J. Waltz et al., 1993). As the 
meaning underlying an interventionist behavior varies, depending on the client context in 
which it occurs, measurement of treatment competence is a more subtle and complex 
process than measurement of adherence (Hogue et al., 1996; J. Waltz et al., 1993). 
High fidelity implementation requires both adherence and competence (Hogue et 
al., 1996). Competent implementation is impossible without adherence to treatment 
guidelines; yet adherence alone is insufficient to assure competent delivery (Barber et al., 
2003; Perepletchikova et al., 2007; J. Waltz et al., 1993).  
Treatment fidelity measurement. The measurement of treatment fidelity 
involves identifying theoretically distinctive intervention elements to ensure reliable 
differentiation among treatments when conducting comparative research (Dane & 
Schneider, 1998; Hogue, Liddle, Singer, & Leckrone, 2005; Moncher & Prinz, 1991; 
Santacroce et al., 2004; Stein et al., 2007). The extent to which treatments differ from 
each other can be sufficiently determined through the development of detailed, precise, 
protocol-derived measures that include proscribed as well as prescribed behaviors 
(Mowbray et al., 2003; J. Waltz et al., 1993). 
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Treatment manuals. A detailed manual that describes the treatment protocol is an 
essential precondition of treatment fidelity assessment (Rounsaville et al., 2001; J. Waltz 
et al., 1993). Although the existence of a treatment manual cannot ensure purity of 
implementation, it does increase the likelihood of consistent, standardized delivery (Bellg 
et al., 2004). Treatment manuals should clearly specify appropriate interventions and 
desired therapeutic behaviors to guide training, implementation, and identification of 
fidelity assessment criteria (Rounsaville et al., 2001; Santacroce et al., 2004). In addition, 
theoretical foundation and therapeutic objectives are appropriately explicated in the 
treatment manual (Bellg et al., 2004; Mowbray et al., 2003; Santacroce et al., 2004).  
Although manual-guided treatment protocols are the recognized standard, 
treatment fidelity studies inconsistently use manuals (Bellg et al., 2004; W. R. Miller & 
Wilbourne, 2001; Mowbray et al., 2003; Perepletchikova et al., 2007). In addition, when 
manuals have been developed to guide psychotherapeutic treatments, they seldom 
provide adequate detail regarding competence criteria (J. Waltz et al., 1993).  
Instrument design. The design of treatment fidelity instruments differs 
significantly in accordance with the treatments they have been developed to measure. 
Complex treatment protocols require tools of correspondingly greater complexity to 
assess interventionist adherence and competence (Ogrodniczuk & Piper, 1999; Orwin, 
2000; Perepletchikova et al., 2007; Stein et al., 2007; J. Waltz et al., 1993). However, 
lengthy, complicated measures can become unwieldy and impractical to use 
(Ogrodniczuk & Piper, 1999). Congruence with the theoretical assumptions underlying 
the interventions is a primary consideration when developing a fidelity measurement tool 
(J. Waltz et al., 1993).  
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Scale design. The construction of scale items also varies widely. A simple and 
economical design involves a checklist format, rating the incidence and frequency of 
prescribed or proscribed interventions (J. Waltz et al., 1993). This method can obscure 
subtle differences in interventionist behaviors and may hamper assessment of inter-rater 
reliability resulting from difficulty detecting differences between coding scores (Stein et 
al., 2007). Advantages of dichotomous measures include their economy, simplicity, and 
elimination of outliers (Stein et al., 2007; J. Waltz et al., 1993). A Likert format is an 
alternative item design allowing ratings of frequency or intensity of a given behavior 
(DeVellis, 2003). Likert scaling is more complex than dichotomous scaling, requiring 
more intensive rater training to achieve satisfactory inter-rater reliability (J. Waltz et al., 
1993).  
Treatment fidelity data collection. Measurement of treatment fidelity requires 
collection of implementation data. A variety of strategies can be used to accomplish this. 
Direct methods include audiotapes, video recordings, and in vivo observation of 
implementation, while indirect methods rely on evidence obtained from sources such as 
therapist self-reports, process note review, and checklists (Perepletchikova et al., 2007; J. 
Waltz et al., 1993). Although direct measures are more complex and costly than indirect 
methods, they are considered the gold standard for collection of fidelity evidence for 
research (Bellg et al., 2004; Santacroce et al., 2004; Stein et al., 2007). Studies have 
found that therapists tend to over-report implementation of psychotherapeutic 
interventions in comparison to the assessment of independent raters (Carroll et al., 1998; 
Chevron & Rounsaville, 1983). While indirect methods can play a valuable role in the 
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training and maintenance of treatment fidelity, they cannot substitute for measures 
involving direct observation (J. Waltz et al., 1993). 
Another important aspect of treatment fidelity measurement is identifying the 
appropriate unit of treatment to be used in the fidelity analysis. Approaches that have 
been used in treatment fidelity research include event-by-event coding, in which each     
therapist utterance is identified as a scoring unit (Wills, Faitler, & Snyder, 1987), scoring 
randomly selected session segments (Luborsky, McLellan, Woody, O'Brien, & Auerbach, 
1985), and coding entire sessions (Carroll et al., 2000).   
Concrete, observable therapist behaviors are specific aspects of the codeable unit 
that need to be considered when assessing treatment fidelity (J. Waltz et al., 1993). 
Focusing on actions of the interventionist helps to distinguish implementation from client 
response behaviors and facilitates measurement of treatment fidelity (Santacroce et al., 
2004).  
Interventionist training. Adequate interventionist training is essential to 
establish and maintain treatment fidelity (Bellg et al., 2004; Moncher & Prinz, 1991; 
Resnick et al., 2005). The purpose of training is to teach new skills, expand and refine 
existing abilities, preserve implementation quality, and minimize drift from the original 
protocol (Bellg et al., 2004; Hogue et al., 1996; Santacroce et al., 2004). Standardized 
training is important to optimize consistency of implementation by interventionists (Bellg 
et al., 2004; Rounsaville et al., 2001). Use of treatment protocol training manuals 
facilitates training standardization (Bellg et al., 2004; Resnick et al., 2005; Santacroce et 
al., 2004). Training variance can be further minimized by having the same instructors 
conduct workshops when multiple sessions are planned (Bellg et al., 2004). 
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No single training approach has demonstrated superiority; however interactive 
teaching strategies that use peer performance feedback have been effective (Grol & 
Grimshaw, 2003).  A manual-based curriculum disseminated through didactic instruction 
integrated with experiential teaching strategies such as intervention role-playing has been 
recommended (Bellg et al., 2004; Moncher & Prinz, 1991; Resnick et al., 2005; 
Santacroce et al., 2004). 
Rater selection and training. The selection of raters who will make judgments 
regarding the quality of implementation is a critical aspect of treatment fidelity research. 
Raters selected to assess and code treatment fidelity should possess expertise comparable 
to that of the interventionist (Moras & Hill, 1991; Stein et al., 2007; J. Waltz et al., 1993). 
The complexity of the fidelity instrument and the degree of difficulty involved in 
measurement should also be considered when determining rater qualifications. 
Instruments with specific rating systems based on clearly identifiable interventionist 
behaviors may be used successfully by individuals with less expertise, while tools 
requiring consideration of more subtle contextual variables will benefit from raters with 
more experience (J. Waltz et al., 1993). Raters should be not be directly involved in the 
research project; recruitment of unaffiliated individuals will reduce rating bias and 
enhance study reliability and validity (Dumas et al., 2001; Hogue et al., 1996; J. Waltz et 
al., 1993).  
Rater training should include teaching components similar to those used to train 
interventionists (Carroll, Kadden, Donovan, & Zweben, 1994; Hogue et al., 1996; Stein 
et al., 2007; J. Waltz et al., 1993). Detailed, manual-based treatment protocol instruction 
is recommended to ensure that raters comprehend intervention strategies and goals 
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(Carroll et al., 2000; Hogue et al., 1996; Stein et al., 2007; J. Waltz et al., 1993). Rater 
instruction should include opportunities to code practice audio recordings or videotapes 
of pilot cases (Carroll et al., 2000; Dumas et al., 2001; Moncher & Prinz, 1991; Stein et 
al., 2007). Subsequent comparison of trainee results with expert consensus ratings of the 
same tapes will allow determination of inter-rater reliability (Carroll et al., 2000; Stein et 
al., 2007).  Another teaching strategy to facilitate measurement calibration and enhance 
inter-rater reliability is to foster regular discussion among raters regarding their mutual 
interpretation of interventionist behaviors and comparison of ratings (Carroll et al., 2000; 
Dumas et al., 2001; Moras & Hill, 1991).  
Treatment fidelity assessment in brief intervention research. Assessment and 
measurement of treatment fidelity is a fundamental component of empirical testing 
conducted to determine whether a psychosocial intervention, found to be effective in a 
controlled trial, is generalizable and replicable. An extensive review of the prenatal 
substance use brief intervention research found only two studies reporting incorporation 
of treatment fidelity procedures.   
Researchers conducted a randomized clinical trial to measure change in maternal 
alcohol use when partners as well as pregnant women participated in a single-session 
brief intervention (Chang et al., 2005). There is no mention of a manual; the authors 
describe the intervention as structured, incorporating knowledge assessment, goal setting, 
and behavioral modification. Implementation was conducted by the primary investigator 
(a psychiatrist) or master’s-degree-prepared nurse practitioners; all were described as 
clinicians experienced in delivery of the brief intervention. The method used to assess 
treatment fidelity was evaluation of interventionist summary notes. Interventions were 
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not audiotaped and there was no report of use of a fidelity measurement tool or the degree 
of treatment fidelity attained during implementation. As described earlier, G. Chang 
(2005) and colleagues reported significant declines in alcohol consumption in the brief 
intervention group. However, replicability of this study was jeopardized by limitations in 
several of the reported treatment fidelity procedures including (a) lack of a specific 
treatment protocol or quality control methods to assure fidelity in treatment delivery, (b) 
subjective assessment of implementation, and (c) failure to develop and implement 
methods to measure treatment fidelity. 
In another controlled trial, O’Connor and Whaley (2007) studied the effectiveness 
of a brief intervention designed to encourage pregnant women to abstain from alcohol. 
This manual-guided brief intervention is described as incorporating education, cognitive-
behavioral procedures, and goal setting. Interventionists were nutritionists who had 
received training. A fidelity checklist was used to assess inclusion of brief intervention 
content. Before participating in the study, interventionists were required to demonstrate 
100% reliability in conduct of the brief intervention when assessed by means of the 
fidelity checklist. A random sample of interview sessions were audiotaped during the 
study and scored using the fidelity checklist to ensure continued adherence to the 
protocol. Higher rates of abstinence and improved infant outcomes were reported among 
women receiving the brief intervention. The treatment fidelity methods described in this 
study encompass many criteria essential for intervention replication, including (a) 
provision of a manual detailing a specific treatment protocol, (b) intensive training 
measures taken to ensure quality of implementation, (c) objective assessment of 
implementation, and (d) use of a fidelity checklist to assess adherence to intervention 
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content. Treatment integrity would have been further strengthened if methodological 
procedures had been incorporated to facilitate assessment of interventionist competence 
and evaluation of audiotapes by unaffiliated raters. 
Gaps in the Literature 
Brief intervention studies carried out with the general population and with 
pregnant women have reported significant reductions in harmful substance use, yet few 
of these efficacious interventions have been successfully translated from the research 
setting. It is clear that conducting a rigorous, randomized controlled clinical trial is not 
enough to ensure that an intervention will be used in practice. Most brief intervention 
studies have not sufficiently incorporated research strategies that are needed to assure 
faithful delivery of behavioral treatments, determine their effectiveness, and facilitate 
adoption.  
The dearth of brief intervention studies using non-specialists or frontline staff in 
the role of interventionist draws attention to another area that warrants study. The 
increasingly costly nature of healthcare mandates investigation of cost-effective 
intervention protocols that reflect the reality of standard staffing in primary health care.  
This literature review, by presenting what is known about prenatal substance use, 
brief intervention research, and treatment fidelity, has revealed topics that merit further 
examination. These areas frame the contribution that this study will make to the current 
knowledge.  
Summary 
This chapter presented a review of the literature relevant to this study. MI and 
SDT concepts were aligned to provide a sturdy conceptual framework that guided 
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development of the treatment fidelity instrument. An overview of deleterious effects 
associated with prenatal consumption of alcohol, tobacco, marijuana, opioids, cocaine, 
and amphetamines was presented. A chronology of historic events in the scientific 
community provided rationale for the emergence of treatment fidelity. The importance of 
assessing treatment fidelity in the controlled study of experimental behavioral 
interventions was illuminated. There is convincing evidence in support of brief 
interventions in terms of efficacy, efficiency, and cost-effectiveness. Although the 
literature has contributed positive information regarding the promise of brief 
interventions in reducing substance use during pregnancy, there is a need for a controlled 
brief intervention research study with this population that incorporates rigorous treatment 
fidelity strategies sufficient to assure delivery of the independent variable. It is this gap in 
the literature that I sought to address in this study. 
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Chapter 3 
Methods 
This chapter presents a description of the IAC brief opportunistic intervention 
followed by a detailed outline of the methods and procedures that were used in the study. 
The research design, sample, setting, institutional approval of methods for protection of 
human participants, data collection procedure, instrumentation, and data analyses are 
addressed.  
IAC Brief Opportunistic Intervention 
The IAC is a structured, substance-specific protocol developed to facilitate timely 
provider response to the disclosure of ATOD use during pregnancy.  The steps of the IAC 
are outlined in a manual (Chasnoff & McGourty, 2003) that includes scripted options and 
suggested language for the interventionist to use depending on the woman’s response. 
The manual contains photographs of substance-exposed children manifesting clinical 
effects of prenatal alcohol, tobacco, or illicit drugs. The photographs are accompanied by 
text that describes the potential consequences of use. Per IAC protocol, the interventionist 
displays photographs depicting negative outcomes associated with the specific substances 
that the woman has reported using and discusses their potential consequences during 
pregnancy.  
Remarks are prefaced with the words “I am concerned…” when discussing 
negative sequelae associated with prenatal substance use to avoid conveying an 
intimidating or threatening attitude. Women are unambiguously advised to discontinue, 
rather than decrease, ATOD use. The interventionist continuously assesses the woman’s 
demeanor and responsiveness throughout the intervention to determine her reaction, and 
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modify the approach accordingly. If the woman becomes distressed, the interventionist is 
advised to yield in the interest of maintaining a therapeutic relationship, and defer further 
treatment until a future opportunity presents itself. Referrals to drug, alcohol, or smoking 
cessation will be offered as indicated. If the woman is open to referral, the provider will 
facilitate an appointment to the appropriate source. 
Research Design  
I used a methodologic research design to frame the development of a treatment 
fidelity instrument used to measure the degree of adherence and competence with which 
frontline staff members implemented the IAC brief opportunistic substance-use targeted 
intervention in the simulated prenatal clinic setting. I also assessed measurement validity 
and reliability associated with use of this instrument.  
Research protocol. I conducted this study in six phases, including (a) tool 
development, (b) standardized patient hiring and preparation, (c) rater hiring and training, 
(c) frontline prenatal clinic staff recruitment and preparation, (d) brief opportunistic 
intervention implementation simulation, and (e) treatment fidelity coding and scoring. 
Each of these phases is described in detail as follows:  
Phase I: Tool development.  
Step 1: Identification of essential elements of the IAC. I identified the essential 
elements involved in accurate implementation of the IAC brief opportunistic intervention 
from the manual describing the clinical protocol. Guided by the conceptual framework 
derived from the union of MI and SDT, I used these elements to develop the instrument 
that would be used to assess treatment fidelity during IAC implementation.   
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Step 2: Construction of scale items. Once I identified the essential components 
involved in IAC implementation, I translated them into statements of observable 
interventionist behavior. The statements were arranged in accordance with the order in 
which they were likely to be introduced during implementation. For any action that I 
judged to comprise both adherence and competence components, I constructed paired, 
sequenced statements using the same root phraseology to facilitate independent rater 
recognition and scoring of the behavioral elements during implementation, a pattern I 
adapted from the Yale Adherence and Competence Scale (Nuro et al., 2005).  
Step 3: Development of item scaling Following development of the scale items, I 
selected an appropriate scaling option to reflect the occurrence or non-occurrence of the 
behaviors. I chose Likert scaling, which allows measurement of the intensity of behaviors 
along a continuum, because it was most congruent with the complexity and assumptions 
underlying the IAC treatment modality. 
Step 4: Identification of coding units. The next step involved defining what was 
to be treated as a codeable unit. Possible approaches range from coding timed segments 
of a treatment session to identifying an entire session as a codeable unit. For this study, 
the segment of the audio recording involving IAC implementation comprised the 
codeable unit.  
Step 5: Assessment of content validity. During this step of the tool development 
phase, I sought the opinions of content experts I. J. Chasnoff and R. F. McGourty, the co-
developers of the IAC brief opportunistic intervention (Appendix A). I provided each 
with a content review questionnaire that enabled them to judge the instrument’s specific 
adherence and competence components in terms of how comprehensively they 
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represented the underlying concepts of the IAC brief opportunistic intervention 
(Appendix B). The questionnaire included 4-point rating scales to capture the content 
reviewers’ assessment of the clarity and sufficiency of each scale item (1 = not very clear 
or not sufficient, to 4 = clear or sufficient). The reviewers also judged the relevance of 
each item to the content domain to determine if it should be deleted or retained, and 
added comments as desired. The original draft contained 26 scale items (14 adherence 
components and 12 competence components) that were framed as questions, each with a 
5-point Likert scale with the scale anchors “not at all,” “a little,” “somewhat,” “quite a 
bit,” and “extensively” (Appendix C).  
Based on content expert feedback, I made several revisions to the first instrument 
draft. I changed scale items from questions to declarative statements, revised Likert scale 
anchors to reflect ordered levels of agreement, and included an “undecided” option to 
provide a neutral middle value. I changed the Likert scale anchors for the competence 
components to “strongly disagree,” “disagree,” “undecided,” “agree,” and “strongly 
disagree.” For the adherence components, judged by the content experts to require a less-
nuanced gradation, I assigned a 3-point scale labeled “disagree,” “undecided,” and 
“agree.” In the second item, I changed the phrase “encouraging tone of voice” was 
changed to “positive tone of voice” to clarify and enhance audible recognition of this 
competence attribute. I developed new scale items to allow measurement of aspects of 
implementation that had not been adequately addressed in the first draft, and I deleted 
several items perceived to duplicate measurement of behaviors assessed by other items.  
At this point, the revised instrument contained 19 items, 10 describing adherence 
behaviors and 9 addressing competence behaviors (Appendix D). Of these items, I 
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grouped 16 into sequenced pairs with an adherence statement describing implementation 
of a specific behavior followed by a competence statement describing the quality of 
implementation. I determined that item 7, “the interventionist conveys awareness of the 
woman’s willingness to hear information regarding the effects of prenatal substance use,” 
was a stand-alone overriding competence behavior. I judged that two remaining items 
described independent adherence IAC behaviors: item 12 involved providing openings 
for the woman to react, and item 15 addressed the referral of medical questions.  
When the content experts reviewed the second draft of the IAC instrument, they 
suggested additional modifications, and I further revised the instrument in accordance 
with their comments. In items 13 and 14, I replaced the ambiguous phrase “providing 
feedback” with “responding to the women’s reaction.” The content experts recommended 
deleting item 15, “the interventionist verbalizes praise when acknowledging the woman’s 
decision to discuss her drug use” because it would not apply to those women who chose 
not to discuss their drug use. Moreover, they thought that acknowledging a woman’s 
decision was the key element of this aspect of the IAC, and this had already been 
addressed in item 14 as an adherence component. I made a final revision to the second 
draft in accordance with content experts’ recommendation concerning item 19, “the 
interventionist refers medical questions asked by the woman to the physician or nurse.” 
Recognizing that some women would not have these questions, I added a “not 
applicable” option. Finally, I incorporated these revisions into a third draft of the IAC 
treatment fidelity instrument. The content experts endorsed this version without 
recommending additional revisions (Appendix E).  
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Step 6: Item testing and revision. Once the content experts deemed the IAC 
treatment fidelity instrument satisfactory, I conducted preliminary testing. To accomplish 
this, I hired as a research assistant, a clinical social work therapist who was skilled in the 
implementation of the IAC brief opportunistic intervention. I used practice audio 
recordings, made during simulated IAC implementation sessions with standardized 
patients in the role of substance-using pregnant women and myself playing the role of a 
frontline prenatal clinic staff member (see research protocol phase II, step 3), to conduct 
the preliminary testing. Guided by the IAC treatment fidelity instrument, the therapist and 
I independently evaluated, coded, and scored each of the practice audio recordings. We 
then mutually reviewed our results and discussed the clarity and utility of the instrument. 
On the basis of our review, we recognized that the competence items that corresponded to 
adherence items needed a “not applicable” option to provide raters a scoring alternative 
when IAC behaviors did not occur. The content experts approved this revision, resulting 
in the fourth and final version of the IAC treatment fidelity instrument that I used during 
data collection (Appendix F). 
Phase II: Standardized patients. 
Step 1: Standardized patient hiring. I recruited nine nursing students from the 
associate degree nursing program of a local community college as standardized patients 
to portray substance-using pregnant women. These students were paid as research 
assistants. 
Step 2: Standardized patient identities. I created realistic standardized patients 
identities (Appendix G). The identities contained fictitious identity elements (name, age, 
pregnancy history, partner status, medical history, history of substance use, and living 
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conditions) upon which the students based their responses during the simulated 
interviews. Three registered nurse prenatal clinic obstetric case managers evaluated the 
identity scripts to ensure that they were realistic and reflective of actual patient cases.  
Step 3: Standardized patient preparation. I met with the nursing students twice to 
prepare them for their respective standardized patient roles. At the first meeting, I gave 
the nursing students their scripted, standardized patient identities and described the 
simulation plan. I held a second, individual meeting with each nursing student prior to the 
beginning of data collection. At this time, the students participated in practice simulation 
sessions during which I played the role of the frontline staff member. I conducted an 
abbreviated prenatal intake interview, culminating in IAC implementation, with the 
nursing students role-playing their standardized patient identities. I recorded these 
interviews for future use in preliminary testing and revision of the treatment fidelity 
instrument (see research protocol phase I, Step 6) and to facilitate rater training (see 
research protocol phase III, step 2).  
Phase III: Raters.  
Step 1: Rater recruitment. I recruited three adjunct nursing faculty members from 
the associate degree-nursing program of a local community college to serve as raters. The 
faculty members were paid as research assistants. 
Step 2: Rater training. I trained the raters using a curriculum that included 
didactic training regarding the theoretical framework grounding brief interventions and 
detailed discussion of IAC brief intervention implementation strategies (Appendix H). I 
provided each of the raters with the IAC treatment manual that is used to train frontline 
staff member in IAC implementation and as a guide during IAC implementation. In 
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addition, I introduced the raters to the IAC treatment fidelity instrument and gave them 
an opportunity to code and score the practice audio recordings that had been made during 
standardized patient preparation (see research protocol phase II, step 3). To achieve 
consensus and increase the level of inter-rater agreement, the raters and I reviewed and 
discussed their codings and scores, with respect to the ratings that the therapist and I had 
assigned. 
Phase IV: Participant preparation. The frontline staff members recruited to 
participate in the study had already received IAC brief opportunistic intervention 
education in accordance with their job training. Prior to conducting the simulated clinic 
interviews, I met with them as a group to review concepts associated with IAC 
implementation and introduce them to the audio recording process that would be used 
(Appendix I). At this meeting I sought guidance from the frontline staff participants 
regarding the components that they thought necessary in an abbreviated prenatal intake 
interview form that I planned to create for use during the simulations. Subsequent to the 
meeting, I created this form and sent it to the participants via email for their approval 
prior to their participation in the clinic simulations (Appendix J).  
Phase V: Brief opportunistic intervention implementation. During the 
simulated prenatal clinic sessions, the frontline staff participants met individually with 
the simulated patients portraying their scripted identities. In private rooms arranged to 
resemble a clinic office, the participants conducted prenatal intake interviews in 
accordance with the same process used when performing their job duties in their prenatal 
clinic or office. Each room was stocked with an IAC treatment manual and a sufficient 
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number of prenatal intake forms for the participants to use when interviewing the 
standardized patients.  
At the beginning of each interview, I initiated a digital audio recording by 
identifying the pseudonyms of the participant and the standardized patient. Because all of 
the scripted identities assigned to the standardized patients resulted in eventual disclosure 
of prenatal ATOD use during the course of the interview, each session contained a 
segment during which the IAC brief opportunistic intervention was implemented.  
At the completion of each clinic session, I collected the audio recording devices 
and downloaded the digital files into a folder on my home office computer. I used the 
pseudonyms identifying the participant interventionist and the standardized patient to 
label each of the digital files.  
Phase VI: Treatment fidelity coding and scoring. Subsequent to the completion 
of the simulated clinic sessions, this 5-week long phase involving treatment fidelity 
coding and scoring by the raters began. During each meeting, I gave the raters compact 
discs containing 12 or 13 digital audio recordings labeled with pseudonyms designating 
the participants and the standardized patients. In addition to the audio recordings, I 
supplied raters with a corresponding number of copies of the IAC treatment fidelity 
instrument. I shuffled the order of the audio recordings before creating each rater’s 
compact disc to reduce the possibility of any systematic bias that could have affected the 
assignment of scores. I randomized each rater’s weekly set of audio recordings using 
playing cards by: (a) shuffling the deck three times, (b) placing a card face-up from the 
top of the deck on slips of paper designating each of the audio recordings in order, and (c) 
reordering the set of audio recordings from the highest to the lowest ranking card. Suit 
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order from high to low was: spades, hearts, diamonds, and clubs; the ace was considered 
a numeral one.  
I directed the raters to listen independently to the audio recordings to determine 
the section during which IAC implementation occurred and encouraged them to replay 
the recordings as often as they deemed necessary to conduct a comprehensive appraisal. 
Using the IAC treatment fidelity instrument, the raters assessed the adherence and 
competence with which the specific IAC brief opportunistic intervention behaviors were 
implemented and rated them according to the tool’s measurement scale, recording their 
ratings on the tool. Raters used the IAC treatment manual to review implementation 
concepts as needed and wrote comments describing any difficulty they experienced 
assigning scores. I also evaluated and scored each of the audio recordings assigned to the 
raters each week. This afforded me the opportunity to experience rating issues first-hand 
and enhanced my ability to facilitate the weekly meetings. My ratings were used for 
educative purposes only and were not included in statistical analyses.  
I met weekly with the raters. At this time, the raters returned the previous week’s 
audio recordings and completed fidelity tools, and they received a new set of audio 
recordings and fidelity tools. During these meetings, to achieve and maintain high inter-
rater reliability and prevent drift, the raters and I discussed in detail how their 
measurement decisions had been made and any problems they had experienced in 
assigning ratings the previous week. Ratings made prior to meetings were not changed 
during or after the meetings.
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Setting 
The study took place in a mid-sized county in central California. I developed the 
IAC treatment fidelity instrument and standardized patient scripts at a desk in my home 
office. The phases that involved preparation and training of standardized patients and 
participants took place in a nursing classroom on the campus of a local community 
college. The training meeting with the raters occurred in my home. The fifth phase, IAC 
brief opportunistic intervention implementation simulation, took place in offices in the 
nursing department of a community college arranged to simulate the physical 
environment found in primary care prenatal clinics. The final and sixth phase, during 
which the raters independently audited and scored the audio recordings, occurred in the 
raters’ homes. The weekly meetings with the raters took place in my home.   
Sample 
Six participants comprised the convenience sample for this study. I recruited 
participants from among frontline office staff members employed by the county’s 
community health center prenatal clinics or local private obstetrician offices. Inclusion 
criteria for the study were: (a) trained to implement the IAC brief opportunistic 
intervention according to prenatal clinic policy, (b) a minimum of 2 years experience in 
IAC implementation, (c) English-speaking, and (d) adequate hearing and vision to 
conduct an interview. No other criteria were used for inclusion in the study.  
Sample size. The statistical sample for this study was the total number of IAC 
brief opportunistic intervention sessions implemented by the participants. The number of 
sessions determined as adequate for this study was based on calculation of the required 
sample size for inter-rater reliability, measured using the intra-class correlation 
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coefficient (ICC) (Walter, Eliasziw, & Donner, 1998). The key determinants of sample 
size in this calculation are: (a) the level of acceptable inter-rater agreement; (b) the level 
of anticipated inter-rater agreement, and (c) the difference between these two values 
(Walter et al., 1998). I used guidelines for differentiating ICC estimates of inter-rater 
reliability that are clinically meaningful from those that are not (Cicchetti, 1994; Landis 
& Koch, 1977). When the ICC is calculated to estimate levels of inter-rater agreement, 
guidelines recommend the following criteria for determining clinical significance: below 
0.40 is poor; 0.40 to 0.59 is fair; 0.60 to 0.74 is good; and 0.75 to 1.00 is excellent 
(Cicchetti; Cicchetti & Sparrow, 1981). For my study, I judged 0.70 to be the minimum 
level of acceptable inter-rater agreement, a value generally recognized as satisfactory 
(Nunnally & Bernstein, 1994). I anticipated that inter-rater agreement would be 0.85 
because higher levels are reasonably attained when strategies to achieve and maintain 
inter-rater reliability are implemented, including: comprehensive rater training, initial 
calibration through achievement of consensus on practice ratings, and regular 
recalibration meetings (Barber & Crits-Christoph, 1996; Hill, O'Grady, & Elkin, 1992; 
Perepletchikova et al., 2007; Tevyaw & Monti, 2004).  
In accordance with these values, a sample size of 49 interviews was required to 
achieve 0.90 power with an alpha of 0.05 for a one-sided significance test, when 
acceptable inter-rater agreement is 0.70, anticipated inter-rater agreement is 0.85, and 
three raters are used. Each of the six participants recruited for the study were scheduled to 
conduct simulated interviews with each of the nine standardized patients, which would 
have resulted in 54 cases. This number was reduced by circumstances that occurred 
during this phase of the study including a personal conflict that prevented one of the 
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participants returning to conduct scheduled interviews with three of the standardized 
patients, and two audio recordings that were unintelligible. As a result, the precise 
minimum required sample size of 49 cases was achieved. 
Participant recruitment. I mailed introductory letters describing the study to 
provider and frontline staff employed by the prenatal offices and clinics within the county 
(Appendix K). The following week, I contacted these agencies by telephone and spoke 
directly with frontline staff members whose job responsibilities included IAC brief 
opportunistic intervention. During these conversations, I introduced myself, answered 
questions about the study, and invited the staff members to contact me directly if they 
thought they might want to participate. Of the 10 individuals who subsequently contacted 
me to express interest, 6 eventually participated in the study. One interested frontline 
staff member did not meet the inclusion criteria, having had insufficient experience 
conducting the IAC intervention. Three other individuals who did meet the screening 
criteria had schedules that proved to be too demanding to accommodate study 
participation. Participants were compensated for their participation at an hourly rate 
commensurate with their normal employment. 
Procedures for Protection of Human Participants  
I sought approval for the study protocol from the Duquesne University 
Institutional Review Board. I obtained informed consent (Appendix M) from each of the 
frontline staff participants during their initial meeting with me. I informed participants 
that their involvement was totally voluntary and that there were no consequences for non-
participation. There were no anticipated risks to participation and anticipated benefits 
included the dissemination of study findings to a larger health care audience. Consents 
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were not required of the therapist, the standardized patients, or the raters, because these 
individuals were employees rather than participants. Each rater signed a confidentiality 
statement (Appendix N). I used the following measures to protect the confidentiality and 
rights of the participants:  
1. All study documents were kept confidential and free from participant 
identifiers. I assigned each participant a pseudonym that I used in analyzing 
the information that was obtained. Only I knew the matching names and the 
corresponding pseudonyms. The original list containing participant contact 
information and pseudonym cross-referencing was kept in a locked file 
cabinet in my home office throughout the duration of the study and will be 
destroyed when the results have been published.  
2. I listened to the audio recordings to ensure that there were no referents that 
could have potentially identified the participants before the audio recordings 
were given to the raters. I labeled each audio recording with the specific 
participant’s pseudonym. Compact discs containing audio recordings were 
kept in a locked file cabinet in my home office except when they were issued 
to the raters. The computer containing the digital audio recording files of the 
clinic simulations is situated in my home office and is not accessible by any 
individuals other than myself. I set a master password, known only to me, for 
this computer. All study materials will be destroyed at the end of the study 
with the exception of the de-identified files of the digital audio recordings and 
the de-identified database. 
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Procedures for Data Collection 
I collected content validity evidence in conjunction with tool development and 
content expert judgment during phase one of the study. The remaining data comprised 
treatment fidelity scores assigned by the three raters. 
Data collection instrument. During the first phase of the study, I developed the 
IAC treatment fidelity instrument that was used to collect research data. This instrument 
guided measurement of the adherence and competence behaviors associated with 
implementation of the IAC brief opportunistic intervention by the participants. I used a 
demographic tool to collect data describing age, gender, race, level of education, and 
years of experience of the participants (Appendix L). 
Data analysis. I used the PASW Grad Pack 18.0 for Mac (formerly SPSS) to 
analyze descriptive and psychometric data. An assistant professor in the department of 
statistics from a state university provided professional statistical consultation. 
Content validity. I. J. Chasnoff and R. F. McGourty, co-developers of the IAC 
brief opportunistic intervention, served as content experts for this study and conducted 
the content validity analysis described earlier (see research protocol phase I, steps 5 and 
6).  I used the clarity and sufficiency ratings assigned by the content experts to compute a 
content validity index (CVI) quantifying their extent of agreement. The CVI was 
computed by dividing the number of items rated as 4 for clarity (item is clear) and 
sufficiency (item is sufficient), by the total number of items on the instrument (Polit & 
Hungler, 1999; C. F. Waltz et al., 2005). Although a CVI of 0.80 or greater is generally 
considered acceptable (Davis, 1992), Lynn (1986) proposed that when content validity is 
assessed with fewer than six experts, perfect agreement should exist. Accordingly, I 
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continued the process of instrument revisions until I achieved a CVI of 1.0 for all scale 
items.  
Inter-rater reliability. Inter-rater reliability is an estimate of the extent to which 
raters obtain the same result when independently using an instrument to measure an 
observation (Polit & Hungler, 1999). This form of reliability measures the proportion of 
variance in a set of ratings in relation to the total variance of the ratings (James, Demaree, 
& Wolf, 1984). The ICC allows assessment of rating reliability through a comparison of 
the variability of different ratings for a data set and is the statistic of choice for measuring 
levels of agreement between a consistent set of raters (Shrout & Fleiss, 1979). In 
addition, the ICC is the appropriate measure of inter-rater reliability with dimensionally 
scaled data (such as Likert-type scaling) and when more than two raters are used 
(Cicchetti, 1994). As stated earlier, the clinical significance of a given ICC value is 
interpreted as: below 0.40 is poor; 0.40 to 0.59 is fair; 0.60 to 0.74 is good; and 0.75 to 
1.00 is excellent (Cicchetti; Cicchetti & Sparrow, 1981). I calculated the ICC as an index 
of the agreement between the adherence and competence scores assigned by the 
independent raters. Detailed findings regarding the inter-rater reliability results associated 
with use of the IAC treatment fidelity instrument are presented in chapter 4. 
Internal consistency reliability. Internal consistency reliability measures the 
extent of correlation between different items on an instrument that have been designed to 
measure the same construct (Polit & Hungler, 1999). Coefficient alpha is the most 
frequently used index of internal consistency (DeVon et al., 2007). An alpha coefficient 
of 0.70 is considered acceptable for a new scale (DeVellis, 2003); coefficients of 0.80 or 
higher are desirable for established scales (Nunnally & Bernstein, 1994). I calculated this 
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statistic for the combined adherence and competence ratings of the three raters to provide 
an estimate of the degree of interrelatedness associated with the IAC treatment fidelity 
instrument. Details of the internal consistency reliability findings are presented in chapter 
four.  
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Chapter 4 
Results and Discussion 
This chapter includes the findings of this study to develop the IAC treatment 
fidelity instrument and evaluate the psychometric characteristics associated with its use. I 
present a demographic profile of the study participants and describe the results and 
analyses associated with the research questions that address the validity and the reliability 
associated with the instrument. This chapter concludes with a discussion of the findings. 
Recruitment of Study Participants 
After receiving approval for this study from the Duquesne University Institutional 
Review Board, I secured a convenience sample of 6 frontline prenatal office staff 
members as previously described. The phase of the study protocol during which 
participants conducted interviews and implemented the IAC brief intervention with the 
standardized patients in a simulated prenatal clinic setting took place over a 3-week 
period in June 2010. Data collection occurred over a 5-week period in June and July 
2010. During this phase, the raters used the IAC treatment fidelity instrument to assign 
scores that reflected their assessment of the fidelity with which participants implemented 
the IAC brief opportunistic intervention during the simulated clinics.  
Characteristics of Study Participants  
Demographic data for the sample are summarized in Table 1. The frontline staff 
participants in this study were female, ranging in age from 32 to 52 years. In terms of 
race, half described themselves as Hispanic/Latino and the rest as non-Hispanic White. 
Three of the participants reported high school as their highest level of education attained; 
the remaining three participants held an associate degree, bachelor’s degree in health 
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science, and master’s degree in nursing.  The composition of work positions held by the 
participants were 50% (n =3) medical assistant, 33% (n=2) perinatal educator, and 17% 
(n=1) nurse practitioner, reflecting the staffing structure found in primary care practice 
(Grumbach & Bodenheimer, 2004). In terms of prenatal primary care employment 
experience, participants reported 3 to 6 years (n=3), 7 to10 years (n=2), and over 10 years 
(n=1). Participants reported that they had been implementing the IAC brief intervention 
in their practices for 2 to 4 years (n=3), 5 to 7 years (n=1) and more than 7 years (n=2). 
Table 1 
Demographic Descriptions of Participants (N = 6) 
Category          n 
Age 
32 to 42      3 
 43 to 52      3  
Gender 
 Female      6 
Race 
 Non-Hispanic White    3   
Hispanic/Latino     3 
Highest Level of Education 
 High School     3      
 Associate Degree     1     
 Bachelor’s Degree Health Science   1     
 Master’s Degree Nursing    1     
Work Position 
 Medical Assistant    3     
 Perinatal Educator    2     
 Nurse Practitioner    1     
Years Worked in Prenatal Clinical or Office 
 3 to 6      3     
 7 to 10      2     
 More than 10     1     
Years Implementing IAC    
 2 to 4      3     
 5 to 7      1 
More than 7     2 
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Analysis of Research Questions 
Research question 1: “What is the content validity associated with an instrument 
developed to assess treatment fidelity in the delivery of a brief opportunistic intervention 
to decrease the use of alcohol, tobacco, and other drugs by pregnant women?”  
I conducted a content validity assessment to determine the degree to which the 
items included in the instrument adequately represented the fundamental concepts and 
behaviors associated with implementation of the IAC brief opportunistic intervention. I 
assessed content validity with the assistance of content experts I. J. Chasnoff and R. F. 
McGourty, who co-developed the IAC brief opportunistic intervention. I submitted each 
draft of the IAC treatment fidelity instrument for their recursive review until a final CVI 
of 1.0 reflected their complete accord regarding the clarity, sufficiency, and relevance of 
the scale items. The fourth and final version fulfilled this requirement and was the edition 
used by the raters during data collection (Appendix F). 
Reliability test assumptions. The fulfillment of assumptions underlying the 
statistical tests chosen to analyze study data should be considered when evaluating the 
cogency of the statistical conclusions (Sheskin, 2003). I selected Cronbach’s alpha 
coefficient and the ICC the to assess the reliability of the ratings that were assigned by 
the raters using the IAC treatment fidelity instrument. The primary assumptions of these 
parametric tests are that sample data will be distributed normally and will display 
variance comparable to the population to which the findings are generalized (Munro, 
1997). In this study, there was a notable lack of variance among the scores assigned by 
the raters, resulting in an asymmetrical, negatively skewed distribution of data with the 
scores clustered toward the positive end of the scale. Because the ratings in this study 
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varied so little, there was no mechanism that could be applied to transform scale data in 
order to introduce variability and approximate the normal distribution necessary to meet 
the parametric assumptions underlying these tests (Cicchetti & Feinstein, 1990; Sheskin, 
2003). When study data fail to meet the equal variance and normality assumptions 
required of parametric tests, use of nonparametric tests (that typically do not rely on 
assumptions of normal distribution of the variable in the population) should be 
considered (Sheskin, 2003). The Kuder-Richardson formulas (KR 20 and KR 21), which 
are the nonparametric measures of internal consistency analogous to Cronbach’s alpha, 
are only suitable for measures with dichotomous variables (Allen & Yen, 2002), 
rendering these tests unsuitable for this study. Weighted kappa, the ICC’s nonparametric 
equivalent, is mathematically identical to the ICC (Norman & Streiner, 2008) and is 
equally sensitive to the effects of uneven data distribution (Feinstein & Cicchetti, 1990). 
Accordingly, I used Cronbach’s alpha and the ICC in the reliability analyses as specified 
in the study protocol. These parametric tests are consistent with the statistical approaches 
that have been described and recommended for use when developing a measure of 
treatment fidelity (Stein et al., 2007). 
Research question 2: “What is the inter-rater reliability associated with use of an 
instrument developed to assess treatment fidelity in the delivery of a brief opportunistic 
intervention to decrease the use of alcohol, tobacco and other drugs by pregnant 
women?”  
Inter-rater reliability describes the extent of agreement among the scores assigned 
by a group of raters assessing the same behaviors (James et al., 1984). The ICC measures 
the consistency of the relative rankings of scores among raters (Shrout & Fleiss, 1979) 
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and is contingent on the relationships among the ratings rather than relying on raters 
assigning the same scores. ICCs (followed by the 95% confidence interval bounds) 
calculated as indices of the reliability of the adherence and competence subscales in 
addition to each scale item are presented in Table 2. If these calculations were to be 
repeated with multiple samples, the computed confidence intervals are expected to 
encompass the true ICC population value 95% of the time (Munro, 1997). 
Table 2 
IAC Treatment Fidelity Instrument Inter-rater Reliability (N = 49) 
  95% Confidence Interval 
Scale Items ICC
a
 Lower Upper 
Adherence subscale (10 items) 0.64 0.42 0.78 
Competence subscale (8 items) 0.62 0.39 0.77 
    
 1: Bridging comment – adherence 0.44 0.10 0.66 
 2:  Bridging comment – competence 0.56 0.29 0.74 
 3:  “I” message – adherence 0.21 0.00 0.53 
 4:  “I” message – competence 0.15 -0.36 0.49 
 5:  Attempts to share information – adherence (0.00) - - 
 6:  Attempts to share information - competence 0.51 0.22 0.71 
 7:  Conveys awareness of willingness - competence 0.74 0.59 0.85 
 8:  Explains effects of substance use - adherence 0.60 0.35 0.76 
 9:  Explains effects of substance use - competence 0.80 0.67 0.88 
10: Advocates drug abstinence – adherence 0.65 0.43 0.79 
11: Advocates drug abstinence – competence 0.77 0.63 0.86 
12: Provides openings to react – adherence 0.20 0.00 0.52 
13: Responds to woman’s reaction – adherence (-0.07) - - 
14: Responds to woman’s reaction - competence 0.46 0.13 0.68 
15: Acknowledges decision to discuss drugs - adherence 0.61 0.37 0.77 
16: Offers referrals – adherence 0.81 0.69 0.89 
17: Offers referrals – competence 0.80 0.67 0.88 
18: Refers medical questions – adherence 0.70 0.52 0.82 
Note. Values enclosed in parentheses represent paradoxically low ICC calculations. Dashes indicate that 
confidence intervals were not estimated. 
aICC = intraclass correlation coefficient 
 
Guidelines developed by Cicchetti and Sparrow (1981) to examine levels of inter-
rater agreement stipulate that an ICC below 0.40 is poor; 0.40 to 0.59 is fair; 0.60 to 0.74 
is good, and 0.75 to 1.00 is excellent. Accordingly, the ICC values attained for the 
adherence (0.64) and competence (0.62) subscales correspond to a satisfactory level of 
inter-rater reliability.  
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The ICCs calculated for the individual items vary widely, ranging from -0.07 to 
0.81. Ostensibly, the values at the lower end of the range would seem to indicate poor 
inter-rater reliability. To adequately calculate inter-rater reliability, ratings should be 
distributed across the breadth of the scale (C. F. Waltz et al., 2005). There is a well-
known limitation associated with the ICC (which corresponds to the weighted kappa 
measured on an ordinal scale; Fleiss & Cohen, 1973) and other reliability test statistics 
described as the kappa “base rate problem” (Feinstein & Cicchetti, 1990). This problem 
occurs in the presence of data prevalence, when a high proportion of ratings fall under 
only a few of the scale scores (Hoehler, 2000). The paradoxical effects associated with 
data prevalence arise “when the overall proportion of positive results is substantially 
different from 50%” (Hoehler, 2000, p. 500). In this event, the amount of agreement that 
can be expected to occur by chance alone is increased and the size of the correlation 
coefficient correspondingly declines.  
When low ICC scores are computed from high-prevalence measurement data, it is 
appropriate to additionally report the percentage of actual rater agreement as a further 
indicator of inter-rater reliability (Hoehler, 2000). Table 3 displays the observed 
percentage-agreement among the raters for each scale item accompanied by the obtained 
ICC for comparison. Overall, the high level of rater agreement is illustrated by the fact 
that, for all of the scale items, the incidence of no agreement among raters occurred no 
more that 6% of the time. The base rate problem is exemplified in item 5, which showed 
an ICC of 0.00 although the raters were in complete agreement 98% of the time. All of 
the low-ICC adherence items (3, 5, 12, and 13) are associated with levels of complete 
rater agreement of at least 86%. Complete rater agreement for item 4 (the sole 
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competence item showing a low ICC) is 55%. This does not differ significantly from the 
levels of complete rater agreement observed for other competence components, which 
range from 47% to 65%.  
Table 3 
IAC Treatment Fidelity Instrument Rater Agreement Percentage (N = 49)   
 Rater Agreement  
Scale Item None Two  Three ICC 
 1: Bridging comment – adherence 0.02 0.27 0.71 0.44 
 2:  Bridging comment – competence 0.06 0.43 0.51 0.56 
 3:  “I” message – adherence 0.00 0.14 0.86 0.21 
 4:  “I” message – competence 0.04 0.41 0.55 0.15 
 5:  Attempts to share information – adherence 0.00 0.02 0.98 0.00 
 6:  Attempts to share information - competence 0.04 0.33 0.63 0.51 
 7:  Conveys awareness of willingness - competence 0.06 0.41 0.53 0.74 
 8:  Explains effects of substance use - adherence 0.00 0.20 0.80 0.60 
 9:  Explains effects of substance use - competence 0.06 0.41 0.53 0.80 
10: Advocates drug abstinence – adherence 0.00 0.16 0.84 0.65 
11: Advocates drug abstinence – competence 0.02 0.51 0.47 0.77 
12: Provides openings to react – adherence 0.02 0.10 0.88 0.20 
13: Responds to woman’s reaction – adherence 0.00 0.10 0.90 -0.07 
14: Responds to woman’s reaction - competence 0.06 0.33 0.61 0.46 
15: Acknowledges decision to discuss drugs - adherence 0.00 0.33 0.67 0.61 
16: Offers referrals – adherence 0.00 0.10 0.90 0.81 
17: Offers referrals – competence 0.02 0.33 0.65 0.80 
18: Refers medical questions – adherence 0.00 0.12 0.88 0.70 
Note: Rater agreement values reflects the number of scores when raters were in agreement as a percent of 
the total possible scores (N = 49 for each scale item; None = no raters were in agreement; ICC = intraclass 
correlation coefficient; ICC values less than .40 are shown in boldface. 
 
It is clear from direct appraisal of the values displayed in Table 3 that the rater 
agreement percentages alone cannot completely account for the paradoxical ICC results. 
For example, the ICC associated with item 13 is even lower at -0.07 than that obtained 
for item 5, although raters were in complete agreement less often for that item. It is also 
apparent that the high levels of agreement attained in items 16 and 18 did not produce 
contradictorily low ICCs. 
Further analysis of the effect of high prevalence on the inter-rater reliability 
statistic can be evaluated through the direct examination of the raters’ scores. The rating 
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frequency of adherence and competence components among the raters is presented in 
Tables 4 and 5. Adherence items were rated on a 3-point scale, and competence items 
were measured on a 5-point scale.  
Table 4 
IAC Treatment Fidelity Instrument Adherence Items Rating Frequency (N = 49)  
  Adherence Scale Ratings    
Scale Item Rater Disagree Undecided Agree N/A
 
Mean SD 
1:  Bridging comment 
One 10 3 36  2.53 0.82 
Two 2 0 46 2.92 0.40 
Three 2 3 44 2.86 0.46 
3:  “I” message 
One 3 0 46 2.88 0.48 
Two 1 0 48 2.96 0.29 
Three 4 0 45 2.84 0.55 
5:  Attempts to share   
      information 
One 0 1 48 2.98 0.14 
Two 0 0 49 3.00 0.00 
Three 0 0 49 3.00 0.00 
8:  Explains effects of 
 use 
One 4 0 45 2.84 0.55 
Two 1 2 46 2.92 0.34 
Three 5 3 41 2.73 0.64 
10:  Advocates 
 abstinence 
One 4 2 43 2.80 0.58 
Two 2 1 46 2.90 0.42 
Three 3 1 45 2.86 0.50 
12:  Provides opening    
      to react 
One 2 1 46 2.90 0.42 
Two 0 0 49 3.00 0.00 
Three 2 2 45 2.88 0.44 
13:  Responds to  
      reaction 
One 1 1 47 2.94 0.32 
Two 0 0 49 3.00 0.00 
Three 2 2 45 2.90 0.42 
15:  Acknowledges 
 decision to discuss 
 drugs 
One 7 2 40 2.67 0.72 
Two 6 4 39 2.67 0.69 
Three 4 5 40 2.73 0.61 
16:  Offers referrals 
One 4 1 44 2.82 0.57 
Two 1 1 47 2.94 0.32 
Three 3 1 45 2.86 0.50 
18:  Refers medical 
 questions
a
 
One 0 0 1 49 0.06 0.43 
Two 1 0 6 42 0.39 1.00 
Three 0 0 2 47 0.12 0.60 
Note: Ratings values represent the frequency with which rater one, rater two, and rater three assigned 
scores for adherence scale items.  
a
 Only adherence component with a “not applicable” rating option 
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Table 5 
IAC Treatment Fidelity Instrument Competence Items Rating Frequency (N = 49)  
   
Competence Scale Ratings 
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SD 
2: Bridging comment 
One 0 3 2 10 31 3 3.92 1.70 
Two 0 0 0   5 42 2 4.69 1.03 
Three 0 0 0 10 36 3 4.45 1.24 
4:  “I” message 
One 0 0 0 18 30 1 4.53 0.82 
Two 0 0 0   5 43 1 4.80 0.77 
Three 1 0 3   6 38 1 4.57 1.02 
6:  Attempts to share  
     information 
One 0 0 0 13 36 0 4.73 0.45 
Two 0 0 1   4 44 0 4.88 0.39 
Three 0 0 1 11 37 0 4.73 0.49 
7:  Conveys awareness 
One 0 1 3 12 33 0 4.57 0.71 
Two 0 0 3   9 37 0 4.69 0.59 
Three 0 1 2 10 36 0 4.65 0.66 
9:  Explains effects of  
     use 
One 0 2 0 12 33 2 4.43 1.16 
Two 0 0 0   3 45 1 4.84 0.75 
Three 0 0 1   3 42 3 4.59 1.24 
11: Advocates  
     abstinence 
One 0 0 0 17 31 1 4.55 0.82 
Two 0 0 0   6 41 2 4.67 1.03 
Three 0 0 0 10 36 3 4.45 1.24 
14: Responds to  
     reaction 
One 0 1 0 10 37 1 4.63 0.89 
Two 0 0 0   1 48 0 4.98 0.14 
Three 0 0 0 10 37 2 4.59 1.04 
17: Offers referrals 
One 0 0 1 10 33 5 4.22 1.55 
Two 0 0 0   1 46 2 4.78 1.01 
Three 0 0 1   2 43 3 4.61 1.24 
Note: Ratings values represent the frequency with which rater one, rater two and rater three assigned scores 
for competence scale items.  
 
It is apparent from the data displayed in Tables 4 and 5 that the preponderance of 
ratings is clustered under the positive end of the scale, resulting in a negatively skewed, 
sharply peaked distribution. Further evaluation of the prevalence effect can be achieved 
by computing the coefficient of variation (CV) associated with the ratings for each scale 
item. When the CV associated with a scale item is small, this further corroborates that 
ratings fall only under a few of the scale scores. Table 6 displays the mean CV of the 
scores assigned by the raters for each scale item, together with the percentage of 
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complete rater agreement and the calculated ICC for comparison. 
Table 6  
IAC Treatment Fidelity Instrument Inter-rater Reliability Results Comparison (N = 49) 
Scale Item CV 
Complete  
Agreement ICC 
 1: Bridging comment - adherence 20.67 0.71 0.44 
 2:  Bridging comment - competence 31 0.51 0.56 
 3:  “I” message - adherence 15.31 0.86 0.21 
 4:  “I” message - competence 18.77 0.55 0.15 
 5:  Attempts to share information - adherence 1.6 0.98 0.00 
 6:  Attempts to share information - competence 9.26 0.63 0.51 
 7:  Conveys awareness of willingness - competence 14.07 0.53 0.74 
 8:  Explains effects of substance use - adherence 18.21 0.80 0.60 
 9:  Explains effects of substance use - competence 22.83 0.53 0.80 
10: Advocates drug abstinence - adherence 17.54 0.84 0.65 
11: Advocates drug abstinence - competence 22.65 0.47 0.77 
12: Provides openings to react - adherence 9.92 0.88 0.20 
13: Responds to woman’s reaction - adherence 8.43 0.90 -0.07 
14: Responds to woman’s reaction - competence 14.86 0.61 0.46 
15: Acknowledges decision to discuss drugs - adherence 24.95 0.67 0.61 
16: Offers referrals - adherence 16.1 0.90 0.81 
17: Offers referrals - competence 28.18 0.65 0.80 
18: Refers medical questions - adherence 490.13 0.88 0.70 
Note: CV = coefficient of variation; CV values calculated from mean of raters’ scores for each scale item; 
ICC = intraclass correlation coefficient; Complete agreement values reflect percentage when all raters 
selected same score; Values for scale items associated with ICCs less than .40 are shown in boldface.  
 
All of the low-ICC adherence items (3, 5, 12, and 13) are associated with 
significantly lower CVs and higher levels of complete rater agreement in comparison to 
other adherence scale items. As a result, the inter-rater reliability statistics calculated 
from these data must be interpreted in light of the low data variance. This pattern is not 
replicated in the statistics associated with item 4, which is the only low-ICC competence 
item.  
Research question 3: “What is the internal consistency associated with use of an 
instrument developed to assess treatment fidelity in the delivery of a brief opportunistic 
intervention to decrease the use of alcohol, tobacco, and other drugs by pregnant 
women?”  
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Internal consistency reliability assesses the communality of results across items 
within a scale and provides an estimate of the degree to which scale items designed to 
reflect the same construct produce similar results (Trochim & Donnelly, 2007). I 
evaluated the internal consistency reliability associated with use of the IAC treatment 
fidelity instrument using Cronbach’s coefficient alpha. The inter-correlations among 
scale items are presented in Table 7.  
Table 7 
IAC Treatment Fidelity Instrument Internal Consistency Reliability (N = 49) 
 
Scale Items 
Number of  
Items 
Cronbach’s 
Alpha 
Spearman-Brown  
Prophecy r2 
All scale items  18 0.72 0.84 
Adherence subscale 10 0.54 0.70 
Competence subscale  8 0.56 0.72 
Note: Spearman-Brown prophecy reflects estimated reliability coefficient if scale were twice as long. 
An internal consistency analysis using the ratings obtained for the entire scale 
yielded a coefficient of 0.72. While an alpha coefficient above 0.80 is desirable, a 
coefficient of 0.70 is considered an acceptable measure of internal consistency reliability 
for a new scale in the preliminary stages of development (DeVon et al., 2007). Because 
the IAC treatment fidelity instrument was designed to measure the complementary 
dimensions of adherence and competence during implementation, I also calculated 
Cronbach’s alphas separately for the scores obtained from each subscale. The internal 
consistency reliabilities for the adherence and competence subscales were 0.54 and 0.56 
respectively.  
A factor that directly impacts the measurement of alpha is instrument length; the 
greater the number of items included on an instrument, the higher the resulting alpha (C. 
F. Waltz et al., 2005).  As a result, measures of internal consistency reliability are 
increased through the addition of further scale items (DeVellis, 2003). The Spearman-
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Brown prophecy formula allows the estimation of instrument reliability at differing 
lengths based on the known reliability of the measure (Carmines & Zeller, 1979), 
assuming that the additional items retain the nature of the original test (C. F. Waltz et al., 
2005). I used the Spearman-Brown formula to estimate what the reliabilities would be if 
the scales were doubled. The coefficients increased to 0.84 for the entire scale, 0.70 for 
the adherence subscale, and 0.72 for the competence subscale (see Table 7).  
Table 8 presents further analysis of the internal consistency of the instrument 
adherence and competence subscales, accomplished by sequentially deleting items from 
each of the subscales and computing correlation coefficients for the modified subscale. 
Elimination of two items resulted in slightly higher alphas, although neither approached 
the requisite 0.70. For the adherence subscale, the deletion of item 18 produced a higher 
alpha (0.59), in comparison to that of the unmodified version (0.54). For the competence 
subscale, alpha was increased from 0.56 to 0.61 with the omission of item 17.  
Table 8 
IAC Treatment Fidelity Instrument Internal Consistency: Modified Subscales (N = 49)  
Scale Item Deleted Cronbach’s Alpha 
Adherence subscale  1:  Bridging comment  
 3:  “I” message 
 5:  Attempts to share information 
 8:  Explain effects of substance use 
10:  Advocates drug abstinence 
12:  Provides openings to react 
13:  Responds to women’s reaction 
15:  Acknowledges decision to discuss drugs 
16:  Offers referrals 
18:  Refers medical questions 
0.49 
0.50 
0.54 
0.50 
0.48 
0.49 
0.52 
0.49 
0.54 
0.59 
Competence subscale  2:  Bridging comment  
 4:  “I” message 
 6:  Attempts to share information 
 7:  Conveys awareness of willingness 
 9: Explain effects of substance use 
11:  Advocates drug abstinence 
14:  Responds to women’s reaction 
17:  Offers referrals 
0.56 
0.48 
0.53 
0.54 
0.46 
0.52 
0.51 
0.61 
  Note: Values reflect subscale internal consistency with deletion of specified items. 
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Discussion of Results 
This section presents a discussion of the meaning of the results associated with 
the psychometric testing addressed in the research questions that provided the focus for 
this study. The conceptual framework that systematically guided both the development of 
the IAC treatment fidelity instrument and the measurement process that took place during 
this study integrated concepts derived from motivational interviewing and self-
determination. Both of these theories are based on the fundamental assumption that 
individuals are inherently inclined toward positive change (Markland et al.; 
Vansteenkiste & Sheldon). 
Research question 1: “What is the content validity associated with an instrument 
developed to assess treatment fidelity in the delivery of a brief opportunistic intervention 
to decrease the use of alcohol, tobacco, and other drugs by pregnant women?”  
The evidence that I collected during this study established initial content validity 
associated with the IAC treatment fidelity instrument in relation to the content domain of 
the IAC treatment fidelity instrument. A CVI of 1.0 reflected the consensus judgment of 
two singularly qualified content experts regarding the clarity and quality of the items, the 
adequacy with which the items represented the IAC content domain, and the relevance of 
the items to the identified construct.  
When using this instrument to evaluate IAC implementation, the raters reported 
they found it straightforward and inclusive of all of the behavioral elements that required 
their assessment. They reported no difficulty making a choice between the three rating 
options provided for the adherence items (agree, undecided, disagree), but did question 
the need for five levels of agreement for the competence items.  The raters stated they 
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found it challenging to audibly identify behavioral nuances that allowed them to 
distinguish between ratings, such as agree and strongly agree, and they recommended 
using a simpler measuring system for competence items, such as the 3-point scale 
assigned to the adherence items. 
The content validation process that I followed was a two-stage process of 
development and judgment recommended by Lynn (1986).  The first stage of this process 
required me to become conversant with the content domain. To accomplish this, I 
conducted a comprehensive appraisal of the relevant literature that I judged to comprise 
the content domain, which included motivational interviewing, self-determination theory, 
and treatment fidelity, in addition to the IAC brief intervention. This rigorous review 
provided me a thorough awareness of the content foundation, upon which I relied as I 
developed the individual items that would eventually become the IAC treatment fidelity 
instrument. The depth and accuracy of this stage is considered an essential component in 
the process of content validation (C. F. Waltz et al., 2005).   
Through conducting this study, my understanding of the process of measurement 
validity has been strengthened. Validity is a fundamental concept that involves 
ascertaining whether an instrument does actually measure the construct it was developed 
to measure (C. F. Waltz et al., 2005). When validity is defined thus, it is evident that 
construct validity is the unified whole that encompasses all other types of validity 
(Goodwin, 2002; C. F. Waltz et al., 2005)}. Content validation is a necessary theoretical 
step in tool development as it provides evidence regarding the relationship of the content 
domain to the intended interpretation of the scores (Goodwin, 2002). However, content 
validity is limited in that the methods used in the assessment of this type of validity do 
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not provide actual evidence that the scores obtained through measurement support the 
construct (Carmines & Zeller, 1979). Empirical support for the consistency with which an 
instrument’s measures represent a content domain can be provided by accumulating 
validity evidence based on response processes, internal structure, relationships to other 
variables, or the consequences of testing (Goodwin, 2002). This type of validation 
assessment is appropriate during the development of a new instrument, as well as for a 
fully developed tool. A validity assessment based on evidence derived from test content 
alone is insufficient and should be substantiated by evidence collected from validation 
activities that allow assessment of the validity of the inferences derived from the scores 
obtained through the use of an instrument (Carmines & Zeller, 1979; Goodwin, 2002).  
The focus of the first research question that I identified for this study, confined to 
the assessment of content validity, was too limited. A more appropriate research question, 
acknowledging the broader conceptualization of validity, would have been a more 
general inquiry regarding the existence of evidence for validity associated with the 
instrument. My assessment of the validity associated with the IAC treatment fidelity 
instrument would have been strengthened by designing the study to incorporate methods 
that allowed for a wider collection of additional validity evidence.  
I have identified a method that could have been incorporated into the design of 
this study to provide additional evidence of validity. The contrasted or known groups 
approach is a method that can be used to provide evidence based on the empirical 
relationship of predictor scores to other variables (Goodwin, 2002). This strategy 
involves distinguishing two groups of individuals known to possess contrasting levels of 
the attribute the instrument proposes to measure. For this study, I would recruit a second 
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group of frontline staff members without any previous IAC experience.  This group, in 
addition to the experienced frontline staff group, would conduct interviews with the 
standardized patients, culminating in IAC brief intervention implementation.  If the 
treatment fidelity instrument is sensitive to varying levels of IAC implementation 
adherence and competence, presumably, the experienced group mean scores would be 
higher that than those of the inexperienced group.  A significant difference in mean 
scores between the groups would imply that the instrument is able to distinguish between 
their differing levels of IAC treatment fidelity, the construct that the instrument was 
developed to measure.  An additional benefit that would be accrued from this 
modification to the study design is the heterogeneity it would introduce to the sample.  
This might increase the normality of data distribution and the resulting accuracy of the 
reliability analyses.  
Research question 2: “What is the inter-rater reliability associated with use of an 
instrument developed to assess treatment fidelity in the delivery of a brief opportunistic 
intervention to decrease the use of alcohol, tobacco, and other drugs by pregnant 
women?”  
Inter-rater reliability is a psychometric measure that provides an estimate of the 
degree of agreement among raters (C. F. Waltz et al., 2005). It is an attribute of the scores 
obtained through use of the instrument rather than a property of the instrument itself and 
should be assessed with each use of a scale (Guthrie, 2000). The ICCs that I calculated 
for the adherence and competence subscales of the IAC treatment fidelity instrument 
were acceptable for a new instrument at 0.64 and 0.62 respectively. These findings 
provide preliminary support for the use of this instrument to assess treatment fidelity 
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during implementation of the IAC brief opportunistic intervention.  
The ICCs calculated for 13 of the 18 individual scale items ranged from 0.44 to 
0.81; all of these values are within acceptable levels of inter-rater reliability (Cicchetti & 
Sparrow, 1981). The ICCs for the remaining scale items (3, 4, 5, 12, and 13), ranging 
from -0.7 to 0.21, correspond with less than satisfactory levels of inter-rater reliability. 
Respectively, these items were also associated with the highest levels of complete rater 
agreement (0.86, 0.98, 0.88, and 0.90) and lowest data variance as evidenced by the CVs 
calculated for each item (15.31, 1.6, 9.92, and 8.43). These conditions correspond to 
those that have been linked to the base-rate problem, known to generate paradoxically 
low inter-rater reliability statistics (Hoehler, 2000). As a result, I conclude that the low 
ICCs computed for these items are associated with these factors and fail to accurately 
reflect the true levels of inter-rater agreement. 
The level of percentage agreement (0.55) and data variance (CV 18.77) associated 
with item 4, the remaining low-ICC scale component, did not demonstrate sufficient 
magnitude in comparison to other scale items to exert a similar paradoxical influence on 
the calculated inter-rater reliability statistic. Consequently, I believe that the ICC 
associated with this competence item (which addresses the positive tone of voice 
associated with interventionist delivery of the “I” message) is accurate.  
During my weekly meetings with the raters, they frequently discussed and sought 
clarification on precisely what constituted both an “I” message and a positive tone of 
voice. The lack of clarity on this aspect of IAC implementation undoubtedly impacted the 
raters’ measurement of the “I” statement adherence statement (item 3) as well as the 
paired competence statement (item 4). Measurement of these items were further 
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complicated when interventionists used the pronoun “we” instead of “I” in sentences 
expressing their concern. When this occurred, raters expressed uncertainty regarding the 
authenticity of this statement as an “I” message and were inconsistent in their 
measurements of this behavior. Thus, despite the base-rate problem suspected to have 
exerted influence on the ICC calculated for item 3 as described above, I suspect that both 
item 3 and item 4 would benefit from revision. 
 When I developed the study protocol, I did not foresee the manner in which the 
actions designed to ensure accuracy of implementation of the IAC brief opportunistic 
intervention would influence the distribution of data. The frontline staff members that I 
recruited for the study were all experienced in conducting the IAC intervention and I 
further reviewed and discussed IAC implementation behaviors during my preparatory 
meeting with them to ensure consistency of application. As a result, the interventionists 
uniformly implemented the IAC brief opportunistic intervention with high fidelity, and 
the raters had little opportunity to measure instances of substandard implementation. 
Accordingly, the majority of the ratings they assigned were clustered at the positive end 
of the scale.  
I designed the last three phases my study protocol to occur in successive 
increments, with each concluding prior to the subsequent phase. Once the simulated 
clinics had taken place and the interviews between the interventionists and the 
standardized patients had been recorded, I began to meet with the raters. Each week, 
when I met with the raters to discuss their scores, I was encouraged by the significant 
agreement that was evident among their ratings. I did not analyze the scores obtained 
through the raters’ use of the instrument until the data collection phase involving the 
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raters had concluded. As result, I did not recognize the impact that high-fidelity 
implementation had exerted on the reliability assessments until my statistical analyses 
were completed. 
Retrospectively, I have identified alterations to my study protocol that would have 
increased sample heterogeneity and minimized the occurrence of paradoxically low 
reliability scores. Initially, this issue could have been addressed during the participant 
recruitment phase by eliminating the requirement that participants had at least 2 years 
experience in IAC implementation, a modification that would have the added benefit of 
increasing the number of qualified candidates. However, this presumes that frontline staff 
members with less experience would be correspondingly less faithful in their 
implementation of the IAC, an assumption that may not be substantiated. To ensure that 
the raters have opportunities to measure varying levels of treatment fidelity, I would 
ensure that some of the interventionists intentionally implemented the IAC with low 
fidelity during their simulated prenatal clinic sessions. This could be accomplished by 
using trained actors in addition to actual frontline staff members as interventionists. The 
actors could be directed to implement proscribed behaviors and refrain from prescribed 
behaviors associated with the IAC intervention. This would guarantee the occurrence of a 
range of implementation behaviors, fostering comprehensive use of the instrument’s 
scales and a more accurate assessment of the instrument’s reliability.  
I have also considered another alteration in the design of my study that could have 
enhanced my study findings. During the sixth step in the first phase of my study, a 
clinical social work therapist and I independently evaluated, coded, and scored the IAC 
implementation behaviors for each of the 9 practice interviews I had conducted and 
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recorded earlier when training the standardized patients. I had devised this step to provide 
a trial use of the instrument to facilitate content revision. If I had designed this phase as a 
small pilot study and had calculated reliability statistics associated with the ratings we 
assigned, I might have become aware of the base rate problem before conducting the 
simulated clinics and could have redesigned the study protocol at that stage accordingly.  
Research question 3: “What is the internal consistency reliability associated with 
use of an instrument developed to assess treatment fidelity in the delivery of a brief 
opportunistic intervention to decrease the use of alcohol, tobacco, and other drugs by 
pregnant women?”  
The internal consistency reliability statistic provides an estimate of how well scale 
items designed to measure a particular characteristic produce similar results (Trochim & 
Donnelly, 2007). I calculated Chronbach’s coefficient alpha to evaluate the internal 
consistency of the ratings obtained through the use of the IAC treatment fidelity 
instrument during the study. The alpha level for the entire scale items was 0.72, 
considered an acceptable measure for a new instrument (DeVon et al., 2007). The internal 
consistency reliability estimates for both subscales fell below the acceptable range, 
indicating inadequate item intercorrelation.  
I found that deleting two items slightly improved the internal consistency of the 
subscales. When item 18 was removed, the alpha value of the adherence subscale 
increased from 0.54 to 0.59. This item, which was developed to allow measurement of 
interventionists’ response when presented with medical questions outside of their scope, 
primarily concerns medical assistant practice. As the sole adherence item offering a not 
applicable rating option, this item was rated as not applicable in 94% of the cases. In 
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retrospect, this item reflects a practice issue that exists independent of IAC 
implementation and does not make a meaningful contribution to the assessment of IAC 
treatment fidelity. 
The alpha of the competence subscale increased from 0.56 to 0.61 with the 
deletion of item 16.  The intent of this item was to operationalize the desired quality of 
interventionist behavior, characterized as “respectful,” when offering referrals. During 
rater meetings that took place during data collection, ambiguity regarding the 
interpretation of the term “respectful” emerged during the weekly discussions of rating 
assignments. Raters expressed that they were uncertain how to identify this behavioral 
attribute audibly. This suggests that revision of this item may increase recognition of this 
behavior during implementation and improve the internal consistency of the competence 
subscale.  
The length of the IAC treatment fidelity instrument is also a relevant factor that 
requires scrutiny when interpreting the computed internal consistency statistics. The 
sturdy relationship between test length and item intercorrelation is illustrated in this study 
in that the alpha coefficient computed for the entire 18-item scale, which encompasses 
both adherence and competence components, exceeds that of the alpha of either subscale, 
which were designed to make these complementary constructs manifest. Ideally, a scale 
developed to measure a specific construct will be composed of items measuring attributes 
of the construct (Polit & Hungler, 1999), producing a measure of internal consistency that 
results from items correlating highly with the designated construct rather than each other 
(DeVellis, 2003). According to the statistical corrections I computed using the Spearman-
Brown prophecy formula, acceptable reliabilities could be attained by doubling the length 
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of the subscales. However, adding redundant items to an instrument for the sole purpose 
of inflating alpha may bloat the instrument without adding meaningfully to measurement 
of the construct (Kline, 1998). During the scale development phase of this study, several 
items that I included in the first draft were perceived as duplicating measures of 
behaviors concurrently assessed by other items. Accordingly, these were deleted as per 
the recommendations of the content experts. The desired end result was a compact 
instrument comprising items designed to reflect operationalization of distinct behaviors 
involved in the implementation of the IAC. Consequently, I surmise that the alphas of the 
resultant subscales were impacted by their length and may underestimate the true internal 
consistency reliability of the scores (Kline, 1998).  
Additional factors that have been reported to influence the value of coefficient 
alpha should also be considered when interpreting internal consistency reliability results. 
Similar to the base-rate paradox described earlier in relation to the ICC, computation of 
the alpha coefficient relies on both variance and normal distribution of test scores (C. F. 
Waltz et al., 2005). Accordingly, data with a skewed distribution will result in 
paradoxically lower alpha values. As previously described, the ratings that arose from 
this study display a pattern of high rater agreement and low variance, mitigating factors 
that should be taken into consideration when evaluating the statistics calculated from the 
ratings of the adherence and competence scale items during this study. As such, it is 
difficult to determine whether the low alpha coefficients for these scales accurately 
reflected the degree to which the scale items correlated to the intended dimensions. 
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Chapter 5 
Summary, Conclusions, and Recommendations 
This chapter presents a summary and the conclusions of this study, which entailed 
the development and psychometric evaluation of a structured instrument to assess the 
treatment fidelity of the IAC brief opportunistic intervention designed to reduce prenatal 
substance use. Limitations of the study are identified. The chapter concludes with 
recommendations for future research and implications for nursing practice. 
Summary  
The IAC brief opportunistic intervention, designed to reduce prenatal substance 
use, is currently implemented by frontline staff (typically registered nurses, licensed 
vocational nurses, or medical assistants) in several areas of the United States (Chasnoff et 
al., 2008; Children's Research Triangle, 2008). Evaluation of treatment fidelity, to 
determine if this and other behavioral interventions are delivered as intended, is essential 
to controlled research (Bellg et al., 2004; Dane & Schneider, 1998; Moncher & Prinz, 
1991; J. Waltz et al., 1993). The specific aims of this study were to develop an instrument 
to measure the treatment fidelity of the IAC brief opportunistic intervention 
implementation, and establish the validity and reliability associated with use of the 
instrument. The long-term goal of this study is to use this instrument in a randomized 
clinical trial assessing the efficacy of the IAC in reducing prenatal ATOD use.  
The conceptual framework that guided this study was a blend of concepts derived 
from motivational interviewing and self-determination theory. Throughout the process of 
instrument development, I drew upon these conceptual frameworks to inform 
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operationalization of the IAC behavioral elements that ultimately took shape as the IAC 
treatment fidelity instrument. 
I conducted this study in six phases. Phase one, tool development, involved 
identification of the essential elements involved in implementation of the IAC and 
translation of these elements into observable behaviors, selection of appropriate scaling 
options, and assessment of content validity. In the second phase, I enlisted nursing 
students as standardized patients and prepared them to portray ATOD-using pregnant 
women. I recruited and trained nursing instructors as independent raters in the third 
phase. During phase four, I recruited experienced frontline prenatal clinic staff members 
who were currently implementing the IAC in practice as study participants. In the fifth 
phase, the participants implemented the IAC with the standardized patients in a simulated 
clinic setting. During the final phase, raters used the instrument developed during the 
course of the study to independently assess the treatment fidelity with which the frontline 
staff implemented the IAC. To estimate the reliability associated with the scores assigned 
by the raters, I used the ICC to calculate inter-rater agreement and Cronbach’s alpha to 
measure internal consistency. The study protocol was consistent with methods that have 
been identified as essential in the development of a treatment fidelity instrument (Stein et 
al., 2007). 
Conclusions 
The content validity evidence that I collected during the tool development gives 
credence to the adequacy with which the IAC treatment fidelity instrument represented 
the IAC content domain. The structure of the tool, with paired adherence and competence 
components formatted as declarations accompanied by Likert-scaled rating selections, 
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was found to be effective.  
The inter-rater reliability statistics I calculated for ratings associated with the 
instrument subscales and most of the individual scale items were satisfactory, findings 
that indicated consistent use of the instrument by the raters during this study (Cicchetti & 
Sparrow, 1981). Based on the secondary analysis I conducted to examine the proportion 
of rater agreement and prevalence associated with each item, factors known to be 
associated with the base-rate problem (Hoehler, 2000), I have concluded that the ICC 
values calculated for the low-ICC  adherence items (3, 5,  12, and 13) were erroneously 
low. Consequently, the inter-rater reliability associated with these items cannot be 
adequately assessed through the ratings obtained from this sample. 
Because the remaining low-ICC item (4), a component of the competence 
subscale, was not conspicuous for either rater agreement or prevalence levels, I conclude 
that the ICC calculated for this item is an accurate estimate of inter-rater reliability. This 
item and its counterpart (low-ICC item 3) were designed to jointly measure the adherence 
and competence with which interventionists express an “I” message. I believe that both of 
these items would benefit from revision to increase their clarity. 
The Cronbach’s alpha coefficient calculated for the ratings obtained for the entire 
instrument, indicated an acceptable level of internal consistency reliability for a new tool 
(DeVon et al., 2007). The significance of this finding is attenuated by the fact that the 
alpha coefficients for the adherence and competence subscales were low. However, the 
blunting influence of high prevalence and low variance of the measurements must also be 
taken into consideration when evaluating the implications of the alpha levels (C. F. Waltz 
et al., 2005). Until this instrument is used to measure ratings obtained with a more 
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heterogeneous sample, enabling a more normal distribution of scores, the question of 
whether internal consistency reliability will improve through item revision remains 
uncertain. The exception I would make to this conclusion is associated with the findings 
discussed earlier in relation to the alphas calculated with the sequential deletion of ratings 
associated with each item.  When item ratings associated with items 16 and 18 were 
removed from the study data, this did afford a modest increase in the alphas calculated 
for each subscale. Based on my analysis, I recommend revising item 16 and removing 
item 18 to enhance subscale internal consistency reliability results. 
Limitations of the Study  
The primary limitation of this study was my protocol, which used only 
experienced interventionists to implement the IAC in a simulated clinic setting. This 
contributed to the consistently high level of treatment fidelity and resulting uniformity of 
ratings that characterized this study’s data and influenced the reliability analyses. 
Because the interventionists were so dependable in their implementation of the IAC, the 
raters had little opportunity to witness instances when implementation occurred with low 
fidelity. Thus all of the ratings were clustered under the positive scale scores. This tool 
development study would have been impractical to conduct in an actual treatment setting. 
In addition to the challenge of recruiting and consenting a sufficient group of participants, 
obtaining the necessary sample size of 49 audio-recorded instances of IAC 
implementation would have taken an inordinate amount of time to achieve, because most 
prenatal interviews do not involve the disclosure of prenatal ATOD use. In a clinical 
setting, increased test score variance could be anticipated, but not guaranteed. 
Implementation by a pool of experienced interventionists could produce data distribution 
 92 
similar to that present in this study that resulted in undependable reliability findings. 
Another potential limitation was related to sample size. The calculation of desired 
sample size required an assumption about the anticipated level of inter-rater agreement 
that would be achieved. Thus, a sample size of 49 was the number required to reject the 
implied null hypothesis (the inter-rater agreement is 0.70) versus the implied alternative 
hypothesis (the inter-rater agreement is greater than 0.70 with power 0.90, alpha 0.05, 
and anticipated agreement 0.85). Consequently, this sample size would be large enough 
to reject the null hypothesis 90% of the time when the observed difference between the 
null value and the anticipated value was 0.15 (0.85 minus 0.70). After data collection had 
concluded and the statistical analysis was complete, it became evident that my a priori 
assumption regarding the anticipated level of inter-rater agreement was not substantiated, 
because none of the observed ICCs calculated for the subscales or the individual items 
approached 0.85. Questioning whether increasing the number of participants would have 
had an appreciable impact on the ICCs, I concluded that it was sample homogeneity, 
rather than sample size, that was the issue. When the high proportion of rater agreements 
are taken into consideration in tandem with the observed ICCs, this supports the 
probability that these were paradoxical results that can be attributed to the prevalence 
effect (Hoehler, 2000).  
Recommendations for Future Research 
The results of this study support ongoing evaluation of the IAC treatment fidelity 
instrument. Before this instrument can be relied upon as a measure of IAC treatment 
fidelity, it must be subjected to revision and further psychometric testing to gather 
empirical evidence of validity and reliability associated with the instruments measures. 
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Further development of the instrument should involve study in a simulated setting using a 
known contrasted groups design, one group with IAC experience and one without. This 
method will allow assessment of construct validity through an analysis of the extent to 
which the instrument’s measurement is able to distinguish the two groups. This important 
psychometric step is needed to establish the treatment fidelity linkage between the 
instrument’s measurement and the theoretical constructs that underpin implementation of 
the IAC intervention before the tool is tested in an actual clinical setting.  
The outcomes of future reliability testing will depend on obtaining heterogeneous 
samples and normally distributed data to minimize the occurrence of paradoxically low 
reliability scores. This could be accomplished by instructing some interventionists to 
deliberately implement the IAC with low fidelity. Based on the findings of these further 
validity and reliability analyses, the instrument items should be reviewed to determine if 
they adequately represent and measure the IAC content domain. 
I encourage researchers who take on the challenge of instrument development to 
embrace a wider view of validity and design their research questions accordingly. The 
process involved in the assessment of content validity is meaningful and essential to the 
development of an instrument designed to reflect a specific content domain. However, 
content validity alone does not offer the necessary precision needed to serve as a 
benchmark of the validity of the instrument’s measurements. Determination of the degree 
to which an instrument actually measures in accordance with theoretically derived 
expectations requires using results obtained from the tool to make judgments about 
validity. Doing so will allow valid inferences to be made regarding the consequences of 
the use of an instrument. 
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Implications for Nursing Practice 
A goal of nursing research is the discovery of stable relationships that can be used 
to improve the human condition (M. E. Rogers, 1970). This study was a first step in the 
development of an instrument to measure the treatment fidelity of the IAC brief 
opportunistic intervention, which was designed to reduce the prenatal use of potentially 
harmful substances. This tool requires further refinement and psychometric testing before 
it can be used in the clinical setting. Therefore, there are no specific nursing practice 
implications at this time. 
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Appendix A 
Content Validity Review Request 
 
Antonia Torrey RN, MSN 
8315 Portola Road  
Atascadero, CA 93422 
805 769-6705 
torreya@duq.edu 
 
 
February 14, 2010 
 
 
Dear Dr. McGourty and Dr. Chasnoff: 
 
 
Thank you again for agreeing to review the “I Am Concerned” (IAC) Fidelity Instrument 
and providing feedback related to its content validity. My intent is to provide an 
instrument that accurately reflects the dimensions of the IAC and can be used to assess 
the faithfulness of its implementation. Guided by a conceptual framework derived from 
motivational interviewing and self-determination theory, I designed this instrument to 
measure both the adherence and competence components associated with IAC 
implementation and believe the result to be consistent with the complexity and 
assumptions underlying the IAC.   
 
I am sending you two documents. One is a first draft of the actual instrument that will be 
used by raters to assess the faithfulness of IAC implementation. This will allow you to 
see the manner in which I have formatted items with their associated Likert-scaled 
responses. In addition, I am sending you a content review questionnaire, which will allow 
you to rate each item in terms of its clarity, sufficiency, and relevance; I have also 
included an area to insert optional comments. Your respective ratings will allow me to 
compute a content validity index. I will continue to revise the instrument in accordance 
with your ratings until perfect agreement has been achieved.  
 
Please let me know if you have any questions. I welcome any and all feedback and look 
forward to your review.  
 
 
Sincerely, 
 
Toni Torrey 
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Appendix B 
Content Review Questionnaire 
Reviewer: ______________________ 
Please rate each item’s clarity, sufficiency, and relevance and comment as needed.  
Item Clarity Sufficiency Relevance 
1. To what extent did 
the interventionist 
use a bridging 
comment when 
indicated to move the 
conversation from 
interview to pre-
treatment? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
2. To what extent did 
the interventionist 
use an encouraging 
tone of voice when 
verbalizing bridging 
comments?  
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
3. To what extent did 
the interventionist 
use an “I” message 
when indicated? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
4. To what extent did 
the interventionist 
use a positive tone of 
voice when 
verbalizing “I” 
messages? 
COMPETENCE 
 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
5. To what extent did 
the interventionist 
attempt to share 
information 
regarding the effects 
of prenatal substance 
use? ADHERENCE  
 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
6. To what extent did 
the interventionist 
use a supportive, 
warm approach when 
attempting to share 
information 
regarding the effects 
of prenatal substance 
use? COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
7. To what extent did 
the interventionist 
convey awareness of 
the woman’s 
willingness to hear 
information 
regarding the effects 
of prenatal substance 
use? ADHERENCE  
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
8. To what extent did 
the interventionist 
respectfully convey 
awareness of the 
woman’s willingness 
to hear information 
regarding the effects 
of prenatal substance 
use? COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
9. To what extent did 
the interventionist 
provide feedback? 
ADHERENCE 
 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
10. To what extent 
did the 
interventionist use a 
supportive tone of 
voice when 
providing feedback? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
11. To what extent 
did the 
interventionist 
explain the effects 
that prenatal 
substance use can 
have on the mother, 
baby, and child? 
ADHERENCE  
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
12. To what extent 
did the 
interventionist use a 
nonjudgmental 
approach when 
explaining the effects 
that prenatal 
substance use can 
have on the mother, 
baby, and child? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
13. To what extent 
did the 
interventionist 
describe the potential 
negative 
consequences of the 
woman’s substance 
use? ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
14. To what extent 
did the 
interventionist 
convey empathic 
sensitivity through 
words and tone of 
voice when 
describing the 
potential negative 
consequences of the 
woman’s substance 
use? COMPETENCE 
 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
15. To what extent 
did the 
interventionist 
advocate a goal of 
abstinence rather 
than reduction of 
drug use? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
16. To what extent 
did the 
interventionist use a 
supportive tone of 
voice when 
advocating 
abstinence rather 
than reduction of 
drug use? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
17. To what extent 
did the 
interventionist 
acknowledge the 
woman’s autonomy 
and personal choice? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
18. To what extent 
did the 
interventionist 
respectfully 
acknowledge the 
woman’s autonomy 
and personal choice? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
19. To what extent 
did the 
interventionist 
convey that the 
discussion was a 
collaborative 
interaction in 
contrast to one where 
the interventionist is 
in charge? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
20. To what extent 
did the 
interventionist use a 
supportive approach 
when conveying that 
the discussion was a 
collaborative 
interaction in 
contrast to one where 
the interventionist is 
in charge? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
21. To what extent 
did the 
interventionist 
emphasize the 
greater importance of 
the woman’s own 
decisions, 
confidence, and 
perception of the 
importance of 
changing? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
22. To what extent 
did the 
interventionist 
convey empathic 
sensitivity when 
emphasizing the 
greater importance of 
the woman’s own 
decisions, 
confidence, and 
perception of the 
importance of 
changing. 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
23. To what extent 
did the 
interventionist 
acknowledge the 
woman’s decision to 
discuss her drug use?   
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
24. To what extent 
did the 
interventionist 
verbalize praise when 
acknowledging the 
woman’s decision to 
discuss her drug use? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Item Clarity Sufficiency Relevance 
25. To what extent 
did the 
interventionist offer 
indicated referrals? 
ADHERENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
Item Clarity Sufficiency Relevance 
26. To what extent 
did the 
interventionist 
respectfully offer 
indicated referrals? 
COMPETENCE 
1. Item is not clear 
2. Item needs 
major revision 
to be clear 
3. Item needs 
minor revision 
to be clear 
4. Item is clear 
1. Item is not 
sufficient 
2. Item needs 
major revision to 
be sufficient 
3. Item needs 
minor revision 
to be sufficient 
4. Item is sufficient 
1. Item is not 
relevant and 
should be 
deleted 
2. Item is relevant 
and should be 
retained 
Comment:  
 
 
1  2  3 4 1  2  3 4         1    2 
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Appendix C 
IAC TREATMENT FIDELITY INSTRUMENT – Draft 1 
 
1. To what extent did the interventionist use a bridging comment when indicated to move 
the conversation from interview to pre-treatment? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
2. To what extent did the interventionist use an encouraging tone of voice when 
verbalizing bridging comments?  
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
3. To what extent did the interventionist use an “I” message when indicated? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
4. To what extent did the interventionist use a positive tone of voice when verbalizing “I” 
messages? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
5. To what extent did the interventionist attempt to share information regarding the 
effects of prenatal substance use? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
6. To what extent did the interventionist use a supportive, warm approach when 
attempting to share information regarding the effects of prenatal substance use? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
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7. To what extent did the interventionist convey awareness of the woman’s willingness to 
hear information regarding the effects of prenatal substance use?  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
8. To what extent did the interventionist respectfully convey awareness of the woman’s 
willingness to hear information regarding the effects of prenatal substance use?  
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
9. To what extent did the interventionist provide feedback? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
10. To what extent did the interventionist use a supportive tone of voice when providing 
feedback? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
11. To what extent did the interventionist explain the effects that prenatal substance use 
can have on the mother, baby, and child? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
12. To what extent did the interventionist use a nonjudgmental approach when explaining 
the effects that prenatal substance use can have on the mother, baby, and child? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
13. To what extent did the interventionist describe the potential negative consequences of 
the woman’s substance use?  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
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14. To what extent did the interventionist convey empathic sensitivity through words and 
tone of voice when describing the potential negative consequences of the woman’s 
substance use?  
  
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
15. To what extent did the interventionist advocate a goal of abstinence rather than 
reduction of drug use? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
16. To what extent did the interventionist use a supportive tone of voice when advocating 
abstinence rather than reduction of drug use? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
17. To what extent did the interventionist acknowledge the woman’s autonomy and 
personal choice? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
18. To what extent did the interventionist respectfully acknowledge the woman’s 
autonomy and personal choice? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
19. To what extent did the interventionist convey that the discussion was a collaborative 
interaction in contrast to one where the interventionist is in charge? 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
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20. To what extent did the interventionist use a supportive approach when conveying that 
the discussion was a collaborative interaction in contrast to one where the interventionist 
is in charge? 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
21. To what extent did the interventionist emphasize the greater importance of the 
woman’s own decisions, confidence, and perception of the importance of changing?  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
22. To what extent did the interventionist convey empathic sensitivity when emphasizing 
the greater importance of the woman’s own decisions, confidence, and perception of the 
importance of changing. 
 
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
23. To what extent did the interventionist acknowledge the woman’s decision to discuss 
her drug use?   
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
24. To what extent did the interventionist verbalize praise when acknowledging the 
woman’s decision to discuss her drug use? 
   
COMPETENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
 
25. To what extent did the interventionist offer indicated referrals to the woman?  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
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26. To what extent did the interventionist respectfully offer indicated referrals to the 
woman?  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
Not at all        A Little              Somewhat            Quite a Bit             Extensively 
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Appendix D 
IAC TREATMENT FIDELITY INSTRUMENT – Draft 2 
1. The interventionist uses a bridging comment when indicated to move the conversation 
from interview to pre-treatment. 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
2. The interventionist uses a positive tone of voice when verbalizing a bridging comment.  
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
 
 
 
3. The interventionist uses an “I” message when indicated. 
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
4. The interventionist uses a positive tone of voice when verbalizing “I” messages. 
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
 
 
 
5. The interventionist attempts to share information regarding the effects of prenatal 
substance use. 
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
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6. The interventionist uses a supportive approach when attempting to share information 
regarding the effects of prenatal substance use. 
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
 
 
7. The interventionist conveys awareness of the woman’s willingness to hear information 
regarding the effects of prenatal substance use.  
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
 
 
8. The interventionist explains the effects that prenatal substance use can have on the 
mother, baby, and child. 
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
9. The interventionist use a nonjudgmental approach when explaining the effects that 
prenatal substance use can have on the mother, baby, and child. 
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
 
 
10. The interventionist advocates a goal of abstinence rather than reduction of drug use. 
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
11. The interventionist uses a supportive tone of voice when advocating abstinence rather 
than reduction of drug use. 
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
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12. The interventionist provides openings for the woman to react as information is 
shared. 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
13. The interventionist provides feedback. 
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
14. The interventionist uses a supportive tone of voice when providing feedback. 
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
 
 
15. The interventionist refers medical questions appropriately to the physician or nurse. 
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
16. The interventionist acknowledges the woman’s decision to discuss her drug use.  
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
17. The interventionist verbalizes praise when acknowledging the woman’s decision to 
discuss her drug use. 
   
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
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18. The interventionist offers indicated referrals to the woman.  
 
ADHERENCE 
 
1 ------------------- 2 ------------------- 3  
Disagree             Undecided               Agree 
 
 
19. The interventionist respectfully offers indicated referrals to the woman. 
 
COMPETENCE 
     1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
     Strongly Disagree    Disagree           Undecided             Agree               Strongly Agree 
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Appendix E 
IAC TREATMENT FIDELITY INSTRUMENT – Draft 3 
Interviewer: ________________  Patient: __________________ Rater: ______________ 
1. The interventionist uses a bridging comment when indicated to move the conversation 
from interview to pre-treatment. 
        ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
2. The interventionist uses a positive tone of voice when verbalizing a bridging comment.  
 
      COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
3. The interventionist uses an “I” message when indicated. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
4. The interventionist uses a positive tone of voice when verbalizing “I” messages. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
5. The interventionist attempts to share information regarding the effects of prenatal 
substance use. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
6. The interventionist uses a supportive approach when attempting to share information 
regarding the effects of prenatal substance use. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
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7. The interventionist conveys awareness of the woman’s willingness to hear information 
regarding the effects of prenatal substance use.  
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
8. The interventionist explains the effects that prenatal substance use can have on the 
mother, baby, and child. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
9. The interventionist use a nonjudgmental approach when explaining the effects that 
prenatal substance use can have on the mother, baby, and child. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
10. The interventionist advocates a goal of abstinence rather than reduction of drug use. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
11. The interventionist uses a supportive tone of voice when advocating abstinence rather 
than reduction of drug use. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
12. The interventionist provides openings for the woman to react as information is 
shared. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
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13. The interventionist responds to the woman’s reaction. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
14. The interventionist uses a supportive tone of voice when responding to the woman’s 
reaction.  
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
  
 
15. The interventionist acknowledges the woman’s decision to discuss her drug use.  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
17. The interventionist offers indicated referrals to the woman.  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
18. The interventionist respectfully offers indicated referrals to the woman. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
         Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
19. The interventionist refers medical questions asked by the woman to the physician or 
nurse.  
ADHERENCE 
1 ------------------- 2 ------------------- 3      
      Disagree               Undecided                Agree 
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Appendix F 
IAC TREATMENT FIDELITY INSTRUMENT – Final Version 
Interviewer: ________________  Patient: ____________________ Rater: ____________ 
1. The interventionist uses a bridging comment when indicated to move the conversation 
from interview to pre-treatment. 
        ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
2. The interventionist uses a positive tone of voice when verbalizing a bridging comment.  
 
      COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
☐  Not applicable; no bridging comment was verbalized 
 
3. The interventionist uses an “I” message to express concern when indicated.  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
4. The interventionist uses a positive tone of voice when verbalizing “I” messages. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
☐  Not applicable; no “I” message was verbalized 
 
5. The interventionist attempts to share information regarding the effects of prenatal 
substance use. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
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6. The interventionist uses a supportive approach when attempting to share information 
regarding the effects of prenatal substance use. 
 
 COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
☐  Not applicable; the interventionist did not attempt to share this information. 
 
 
7. The interventionist conveys awareness of the woman’s willingness to hear information 
regarding the effects of prenatal substance use.  
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
 
 
8. The interventionist explains the effects that prenatal substance use can have on the 
mother, baby, and child. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
9. The interventionist use a nonjudgmental approach when explaining the effects that 
prenatal substance use can have on the mother, baby, and child. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
☐  Not applicable; the interventionist did not explain the effects of prenatal substance 
use. 
 
 
10. The interventionist advocates a goal of abstinence rather than reduction of drug use. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
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11. The interventionist uses a supportive tone of voice when advocating abstinence rather 
than reduction of drug use. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
☐  Not applicable; a goal of abstinence was not advocated 
 
 
12. The interventionist provides openings for the woman to react as information is 
shared. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
13. The interventionist responds to the woman’s reaction. 
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
14. The interventionist uses a supportive tone of voice when responding to the woman’s 
reaction.  
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
☐  Not applicable; the interventionist did not respond to the women’s reaction 
  
 
15. The interventionist acknowledges the woman’s decision to discuss her drug use.  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
 
 
16. The interventionist offers indicated referrals to the woman.  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3  
       Disagree               Undecided                Agree 
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17. The interventionist respectfully offers indicated referrals to the woman. 
 
COMPETENCE 
                   1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5 
        Strongly Disagree    Disagree        Undecided             Agree               Strongly Agree 
☐  Not applicable; no referrals were offered to the woman 
 
 
18. The interventionist refers medical questions asked by the woman to the physician or 
nurse.  
 
ADHERENCE 
1 ------------------- 2 ------------------- 3      
      Disagree               Undecided                Agree 
☐  Not applicable; interventionist is a physician or nurse.  
☐  Not applicable; no medical questions were asked by the woman 
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Appendix G 
Standardized Patient Identities 
Standardized Patient  - 1 
Name Emma Abbott 
DOB - Age  September 3, 1971 – 38 years 
G/P      GPTAL 3/0         3 – 0 – 0 – 2 - 0 
LMP March 28, 2010  
EDD January 1, 2010 
Partner status  You are no longer involved with the father of your baby  
Obstetric hx You had two therapeutic abortions in your twenties. 
Medical hx Allergic to tetracycline - reaction is hives and difficulty breathing. 
You have had irritable bowel syndrome for several years with 
abdominal pain, bloating, and gas. You take hyoscyamine one tablet 
(0.125 mg) every 4 hours as needed for cramping 
Substance use 
history 
 
 
 
Response to 
interviewer  
You have a long history of alcohol use and you continue to drink 
every day, including hard liquor. You do not like to be preached to 
about drinking because your mom drank when she was pregnant 
with you and you turned out ok.  
 
Alcohol: 2 or 3 drinks/day – you have continued since learning you 
were pregnant  
Tobacco: you quit smoking 10 years ago 
Drugs: no drug use 
IAC Intervention: You are resistant to the IAC and become angry 
when the interviewer tells you about the consequences of prenatal 
alcohol exposure.  
Referrals: You refuse all referrals and you are insulted that the 
interviewer is suggesting that you need help.  
Nutrition You eat a balanced diet overall 
General 
demeanor 
You are resistant to any criticism of your alcohol intake and you 
communicate this to the interviewer in no uncertain terms.   
Housing 
Environment 
You rent a house in Templeton and live alone 
Physical Needs You have MediCal coverage for your pregnancy  
Support System You have good support from family and friends in the area  
Vocation You have a part-time job working in a feed store in Templeton 
 
Standardized Patient  - 2 
Name Cathy Silverman 
DOB - Age  October 19, 1987 – 22 years 
G/P      GPTAL 5/1         2 – 1 – 0 – 2 - 2 
LMP January 11, 2010  
EDD October 18, 2010 
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Partner status You are not involved with the father of this baby (who is also the 
father of your other children) and he is unaware of this pregnancy. He 
was physically and verbally abusive to you and your daughters and 
you left him and the relationship before you discovered you were 
expecting. You do not want him to know where you are.  
Obstetric hx You had a therapeutic abortion in 2003 and a miscarriage the next 
year. You have two-year-old twin daughters, Jill and Jamie. They 
were born in 2008 by C/S at 35 weeks gestation and stayed in the 
NICU for 10 days. You considered terminating this pregnancy for 
some time but you have decided to keep the baby. 
Medical hx NKA – no significant history 
Substance use 
history 
 
 
 
 
 
Response to 
interviewer 
You have a history of substance use. You are currently smoking 10 
cigarettes daily. You smoke marijuana and use methamphetamines 
and now that you have decided to keep the baby you have also 
decided that you will not use drugs and will cut down on your 
smoking. You are not initially truthful about this when the interviewer 
asks you.  
 
Alcohol: you rarely drank before learning of your pregnancy and none 
since 
Tobacco: 1 pack/day for 4 years. 10/day since learning you were 
pregnant 
Marijuana: 1/day for several years. You tell the interviewer that you 
quit when you learned you were pregnant although this is not true as 
you continue to smoke it once or twice a week.  
Methamphetamine: 4 or 5 times/week for 2 years. You tell the 
interviewer that you quit when you learned you were pregnant 
although this is not true, as you have used it several times since you 
learned of your pregnancy.  
 
IAC Intervention: You accept the IAC intervention. When the 
interviewer shows you a picture of a baby exposed to 
methamphetamine, you look away and are visibly upset. 
Subsequently, you will admit to your use when/if the interviewer asks 
you about this 
Referrals: You will accept all offered referrals and state that you are 
through using and will try to quit smoking.  
Nutrition You try to make sure that you and your girls are we eat a balanced 
diet. You have WIC, as well as food stamps and welfare  
General 
demeanor 
You are pleasant, well groomed, and polite.  
Housing 
Environment 
You moved to this are from Southern California in February to escape 
an abusive relationship. You discovered you were pregnant after you 
arrived on the central coast. You are staying at the homeless center 
and you are working on getting housing.  
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Physical Needs You have MediCal coverage, welfare, food stamps and WIC 
Support System You do not have any real social support. Your parents were divorced 
when you were young. Your father remarried and you have not had 
much contact with him in recent years. Your mother lives in Los 
Angeles and you talk to her on the phone from time to time. She has 
physical health issues and is also having a hard time making ends 
meet. You are trying to be a good mother to your two daughters and 
are good about seeking any assistance for which you are eligible.  
Vocation Unemployed 
 
Standardized Patient  - 3 
Name Samantha Carey 
DOB - Age  September 24, 1983 – 26 years 
G/P      GPTAL 1/0         1 –0– 0 – 0 - 0 
LMP April 1, 2010  
EDD January 5. 2011 
Partner status You do not live with the father of your baby, James, but he is very 
involved and supportive. 
Obstetric hx 1
st
 pregnancy.  
Medical hx No significant medical hx – No known allergies 
Substance use 
history 
 
 
 
Response to 
Interviewer  
You like to drink beer and have had a few beers since you became 
pregnant. You read somewhere that it is okay to have a glass of beer 
now and then when pregnant.  
Candid about use and did not think this was a problem. 
 
Alcohol: 1 or 2 beers/day for 3 years – 2 or 3 beers/wk since aware of 
pregnancy 
Tobacco: you have never smoked 
Drugs: none  
IAC Intervention: You accept the intervention and are shocked when 
you learn about the effects of prenatal alcohol use.  
Referrals: you do not accept any referrals, as you do not think you 
need any help. 
Nutrition You do not exercise and drink 3 to 4 sodas per day, down from 5 or 6. 
You are attempting to reduce your fast food intake. You have 
maintained your weight at 220 for the last 3 weeks.  You are 
concerned that your baby will not get enough nutrition if you are not 
gaining weight.  
General 
demeanor 
This pregnancy is unplanned but wanted. You smile frequently during 
visit and are open and candid. 
Housing 
Environment 
You currently live with your grandmother in Arroyo Grande 
Physical Needs You have a WIC appointment. Your friends are giving you a baby 
shower next month. 
Support System Father of baby is supportive and employed in Arroyo Grande. You 
have a couple of close girlfriends and rely on them for emotional 
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support.  
Vocation You are on disability after being injured on the job as a stocker at 
Wal-Mart. You receive $875/mo from state disability. 
 
Standardized Patient  - 4 
Name Grace Downs 
DOB - Age  March 11, 1977 – 33 years 
G/P      GPTAL 3/2         1 –0– 2 – 0 - 2 
LMP February 11, 2010  
EDD November 18, 2011 
Partner status You are currently with your boyfriend Ronald Cole. He is not the 
father of any of your children. You met him at the homeless shelter 
when you were two months pregnant.  
Obstetric hx You have two older children, 13 and 11, born 10/15/96 and 5/10/99. 
You had no problem during pregnancy or delivery and both were 
born vaginally at term. They were removed from your care after 
Child Welfare Services became involved six years ago and you have 
had only occasional contact with them since.   
 
Medical hx Allergic to tegretol (rash) and have a history of mental health 
disorders (bipolar, depression) and have been taking Zoloft (50 mg 
qd) and lithium (slow release 450 mg bid) for some time.  
Substance use 
history 
 
 
 
 
 
 
Response to 
interviewer 
You have smoked marijuana for several years and continue during 
pregnancy and, although you have tried to stop the use of other drugs, 
you have had several relapses on oxycontin and methamphetamine. 
You are currently enrolled in POEG (Perinatal Outpatient Extended 
Group is a community-based perinatal substance use treatment 
program) in the south county and are at risk of being terminated from 
the program due to “dirty” drug tests.  
 
Alcohol: you drink a beer once in awhile but have not had any since 
you became pregnant 
Tobacco: you have not smoked for years  
Drugs: Marijuana daily for several years – you continue to smoke 
marijuana daily during pregnancy  
Oxycontin and methamphetamine 2 or 3/wk when you could get it – 
you have used both a few times since becoming aware of pregnancy 
  
IAC Intervention: You accept the intervention and act shocked when 
you hear about the effects of drug use (although you already have 
heard this information before) 
Referrals: you will accept any offered referrals and will promise to 
follow through 
Nutrition You are have not gained much weight with your pregnancy and were 
underweight to begin with. You have noticed that you have been 
hungrier of late. You eat irregularly and your meals are obtained 
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through various services such as People’s Kitchen and churches. You 
no longer are able to receive services through the community health 
center “Healthcare for the Homeless Program” due to noncompliance 
with meds, appointments and frequent outbursts and rages at the 
staff.  
General 
demeanor 
You present well and are neat and clean. You minimize your drug 
use and its consequences. You can be very manipulative and 
charming and are very experienced with service agencies. 
Housing 
Environment 
You are living with your boyfriend in section 8 housing 
(government-subsidized program that allows lower income families 
the opportunity to rent decent, safe and adequate housing that may 
not be available to them otherwise). 
Physical Needs You are hooked up with WIC and are receiving food stamps and 
welfare payment support. 
Support System Boyfriend – you are estranged from your parents and siblings.    
Vocation Unemployed  
 
Standardized Patient  - 5 
Name Yvonne Castro 
DOB - Age  October 10, 1980 – 29 years 
G/P      GPTAL 1/0         1 –0– 0 – 0 - 0 
LMP March 20, 2010  
EDD December 24, 2010 
Partner status You are married but separated from your husband. Your boyfriend, 
Victorio, is the father your baby. He is an illegal immigrant from 
Mexico.  
Obstetric hx First pregnancy 
Medical hx No known allergies. You have high blood pressure and had been 
taking 25 mg of atenolol daily, but quit when you found out you were 
pregnant. You have been monitoring your blood pressure daily and it 
was 110/70 today. Your OB/GYN is aware that you are not taking 
your medication. You have a history of depression and anxiety that 
continues through your pregnancy, though the frequency and severity 
have decreased. You occasionally have panic attacks when you feel 
you must escape. You had been taking Celexa but quit when you 
found out you were pregnant. 
Substance use 
history 
 
 
 
 
Response to 
interviewer 
You have been a heavy methamphetamine and alcohol user in the past 
but you cut down a lot when you found out you were pregnant and 
have been completely clean for the past 2 weeks.  You have gone to a 
couple of Narcotics Anonymous meetings. You do not feel that you 
need any help to stay sober and clean at this time.  
 
Alcohol: 2 or 3 glasses wine or mixed drinks daily – 2 or 3 /wk since 
you became pregnant and none recently 
Tobacco: you do not smoke  
Drugs: methamphetamine daily at times for the last few years– you 
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have used both a few times since becoming aware of pregnancy but 
not in the last 2 weeks. 
 
IAC Intervention: You accept the intervention and become tearful and 
depressed when you hear about the effects of alcohol and drug use. 
Referrals: you refuse offered referrals and feel you are on the right 
track and do not need any help to stay clean.  
Nutrition You love to eat junk food and have 3 Snickers and a soda daily. You 
listen to information but laugh and say that you understand the 
interviewer is trying to help but, in all honesty, you love your junk 
food too much to quit.  
General 
demeanor 
You are very polite to the interviewer but have been known to get 
angry and yell at others. You are a young woman who masks her 
insecurity and desire for love with a tough, yet funny persona.  
Housing 
Environment 
You are living with your aunt right now. She is supporting you but 
you have to sleep on her couch, as there is not a bed for you.  
Physical Needs You have MediCal.  
Support System You grew up in an abusive and drug-using home. When your mom 
abandoned you at age 12, you lived with your grandmother who uses 
drugs as well. Your boyfriend is possessive, mistrustful and abusive.     
Vocation Unemployed  
 
Standardized Patient  - 6 
Name Helen Parker 
DOB - Age  October 10, 1974 – 35 years 
G/P      GPTAL 1/0         1 –0– 0 – 0 - 0 
LMP February 12, 2010  
EDD November 19, 2010 
Partner status  You think that Ken Jenkins is most likely the father your baby. He is 
homeless, jobless, and lives in his car. He is 44 years old and 
questions paternity. You are not actually sure who the father is but 
none of the potential fathers can be relied upon for support.  
Obstetric hx First pregnancy 
Medical hx No known allergies. You have a history of herpes simplex virus II, 
human papilloma virus, and cervical cancer, high blood pressure and 
had been taking 25 mg of atenolol daily, but quit when you found out 
you were pregnant. You have a history of severe endometriosis and 
have been taking Percocet twice a day. You also have a history of 
depression and a suicide attempt. You were prescribed Zoloft but are 
not taking it for fears of the effects on your baby.  
Substance use 
history 
 
 
 
 
You have a history of drug use and have used methadone, cocaine, 
methamphetamine, and marijuana. Your last “heavy” drug use was 
2008/2009. You were in rehab in Santa Barbara in 2009 but left 
because you could not afford the costs, which were $600/month. You 
have been nauseous occasionally and have been using marijuana now 
and then to help with this. 
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Response to 
interviewer 
 
Alcohol: 2 or 3 drinks month – none since you became pregnant  
Tobacco: you do not smoke  
Drugs: marijuana daily– you have continued to use a few times/week 
since becoming aware of pregnancy  
 
IAC Intervention: You accept the intervention and are surprised and a 
little skeptical to hear that prenatal marijuana use can affect your 
baby.  
Referrals: You are not interested receiving drug & alcohol services 
and really don’t want to hear about them. You do not feel that you 
need any help to stay sober and clean at this time. 
Nutrition You are trying to eat healthy, take vitamins, and avoid hard drugs.   
General 
demeanor 
Your affect is flat and you tell your story with a matter-of-fact tone. 
You are stubborn and don’t like to hear advice that contradicts what 
you believe and want for yourself, but you are not outwardly rude. 
You are depressed and insecure. You are not happy about being 
pregnant but you are dealing with it the best way you know how. You 
did not think you could get pregnant because of your severe 
endometriosis.  
Housing 
Environment 
 
You are living with a friend and sleeping on a couch in the living 
room. Your friend will only let you live there temporarily until other 
living arrangements can be made. Your social worker gave you a list 
of housing resources but you have not called any of them.  
Physical Needs You went to ALPHA Pregnancy Counseling & Support (a nonprofit   
organization) for maternity clothes. You are applying for MediCal but 
have not filed all of the necessary paperwork to receive your benefits 
at this time. 
Support System Your mom is trying to help you but is unhappy with your life choices. 
Now she is trying to be a parent, when she should have been setting 
limits 10 years ago. You feel resentful towards her but have no one 
else who is supportive of you.      
Vocation Unemployed  
 
Standardized Patient  - 7 
Name Sara Deming 
DOB - Age  April 30, 1974 – 36 years 
G/P      GPTAL 1/0         1 –0– 0 – 0 - 0 
LMP January 25, 2010  
EDD November 1, 2010 
Partner status  You have been married to Tom Deming for 6 years. This is your 
second marriage. Tom’s 10 year-old son from a previous marriage 
lives with his ex-wife.  
\  
Obstetric hx First pregnancy 
Medical hx No known allergies. You were in a serious motor vehicle accident 
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(MVA) at age 32 and spent a month in the hospital recovering from 
various injuries. You have been unable to return to your work as a 
medical secretary as sitting in front of a computer screen for any 
prolonged length of time produces neck pain.  
Substance use 
history 
 
 
 
 
 
 
 
 
 
Response to 
interviewer  
Your doctors have prescribed a variety of medications to help you 
deal with post-MVA sequelae. These include narcotic pain 
medications (Oxycontin Percocet, Darvocet, and Vicodin) and anti-
anxiety medications (Valium and Xanax).  You have been using these 
drugs for the last few years to battle depression and loneliness and 
have continued to use them after learning of your pregnancy. You 
have tried to stop on your own but have been unable to do so. Your 
husband is unaware of the extent of your use and does not know that 
you are continuing to take medications since you became pregnant.  
The general practitioner (GP) who has been prescribing these drugs 
does not know that you are pregnant.  
 
Alcohol: none 
Tobacco: none 
Opiates/Valium: daily for three years – 3-4/wk since pregnant 
 
IAC intervention: You will accept the IAC and when the interviewer 
describes the consequences of prenatal opiate use and shows you 
photos of infants who have been Oxycontin-exposed, you are tearful 
and ashamed. 
Referrals: If offered referrals, you tentatively accept them. You 
realize that you might need help. 
Nutrition You have been trying to eat better since you learned you were 
pregnant.  
General 
demeanor 
You are very reluctant to disclose your drug use since becoming 
pregnant and are evasive and obviously ill at ease when asked about 
this.  When you do finally acknowledge that you have been using, you 
are remorseful but do not fully seem to understand your 
responsibility.  
Housing 
Environment 
You live in an apartment in Atascadero with your husband.  
Physical Needs Your husband is employed as an accounting clerk and is going to 
school to become a CPA. He will graduate right after the baby is born 
and has been offered a well-paying job in the agency in which he 
works. Money is somewhat tight but you are managing - the 
apartment in which you live is owned by your mother and your rent is 
quite low. You qualify for MediCal and WIC.  
Support System This was a planned pregnancy. Your husband wanted a large family 
and both sets of parents really want grandchildren. You hoped that 
becoming pregnant would help you get your act together and make 
you feel happier. Your husband is very excited about the baby who is 
a boy.   
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Vocation Unemployed  
 
Standardized Patient  - 8 
Name Jennifer Hansen  
DOB - Age  February 3, 1988 – 22 years 
G/P      
GPTAL 
2/0         2 – 0 – 0 – 1 - 0 
LMP March 10, 2010  
EDD December 14, 2010 
Partner status Father of baby, Rodney, is supportive 
Obstetric hx This was an unplanned pregnancy. You had a therapeutic abortion last 
year.  
Medical hx NKA  
Substance use 
history  
 
 
 
 
 
 
 
Response to 
interviewer 
You were taking approximately 160 mg of Oxycontin w/o a 
prescription up until a month ago. Since then, you have been taking 20 
mg of methadone (off the street) in an attempt to get off the 
Oxycontin. You have not had any methadone for the last 4 days.  
Alcohol: you drink alcohol very rarely and have not had anything to 
drink since learning of your pregnancy 
Tobacco: 15 cigarettes daily for 5 years – you have cut down to 7 
cigarettes per day currently. 
 
IAC Intervention: You accept the IAC intervention and become very 
quiet when the interviewer discusses the consequences of prenatal use 
Referrals: You accept referrals to a drug and alcohol counselor and a 
public health nurse. You do not accept a referral to smoking cessation 
but do accept pamphlets. 
Nutrition You are thin and undernourished. You have not gained any weight 
since becoming pregnant. You want to have a healthy baby but you are 
afraid because of your drug use.  
General 
demeanor 
You are distracted, impatient, agitated and tired.  
Housing 
Environment 
You are living with your boyfriend in a garage/apartment at your 
father’s house.  
Physical Needs You have MediCal coverage. Your boyfriend is working at a local 
grocery store and earns enough to cover your expenses.  
Support 
System 
Your parents are divorced. Your father is a recovering alcoholic and 
heroin addict who has been clean for 13 years. Your mother is a 
prescription drug addict. You do not feel close to either of your 
parents.  
Vocation Unemployed 
 
Standardized Patient  - 9 
Name Angela Meister 
DOB - Age  February 5, 1973 – 37 years 
G/P      GPTAL 5/3        5 – 1 – 2 – 1 - 3 
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LMP February 7, 2010  
EDD November 24, 2010 
Partner status You divorced the father of your children in 2005; you share custody 
of the children. You have lived with Danny Harris, the father of this 
baby, for two years – he is a committed partner. This is his 1st child 
and he is excited. 
Obstetric hx This is your 5
th
 pregnancy; it was unplanned.  All your deliveries have 
been vaginal 
1995: girl – full term – 8 lbs - no complications 
1997: girl – full term – 7 lb 9 oz – no complications 
1998: Miscarriage at 8 weeks followed by D&C 
2000: boy - 37 weeks – 6 lb 3 oz  - was induced early due to problems 
with high blood pressure 
Medical hx No significant medical hx – No known allergies 
Substance use 
history  
 
 
 
 
Response to 
interviewer 
Started smoking after divorce but quit when you found out about this 
pregnancy.  
Drinks a glass of wine once in awhile and you have never used other 
drugs. You did not think that an occasional glass of wine was a 
problem.  
 
Alcohol: 1 glass of wine two or three times a week – this has 
continued since learning of pregnancy.  
Tobacco: ½ pack daily for five years – quit when learning of 
pregnancy 
Drugs: none 
 
IAC Intervention: You accept the IAC intervention and become upset 
when the interviewer discusses the consequences of prenatal alcohol 
use. You do not really believe what she is telling you as you drank 
moderately with your other children and they turned out fine. 
 
Referrals: You do not accept any referrals as you do not think you 
need it. 
Nutrition You eat well and have gained an appropriate amount of weight since 
becoming pregnant. You like to cook and eat a balanced diet.  
General 
demeanor 
Happy about this pregnancy and your children are excited about 
having a little brother or sister. 
Housing 
Environment 
You and your children are living with Danny in a large four-bedroom 
home in a nice neighborhood that he owns. He has a business as a 
house painter and makes a decent living. 
Physical Needs You have MediCal coverage for your pregnancy 
Support System You have several good friends and you are close to your sister who 
lives nearby.  
Vocation You clean houses on a part-time. You like this as it gives you 
flexibility and allows you to be home with your children.  
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Appendix H 
Rater Training Agenda 
 Study Background 
 Confidentiality Agreement 
 Consequences of Prenatal Substance Exposure   
 Screening and Assessment for Prenatal Use of Alcohol, Tobacco, and Other 
Drugs 
 Motivational Interviewing 
 “I Am Concerned” (IAC) Brief Opportunistic Intervention 
o IAC DVD 
o IAC Treatment Manual Distribution 
o Implementing the IAC 
 IAC Treatment Fidelity Instrument 
 IAC Treatment Fidelity Rating Practice 
 Rating Practice Review 
 Weekly Meeting Schedule 
 Distribution of Initial Audio Recording CDs and Fidelity Instruments 
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Appendix I 
Participant Preparation Meeting Agenda 
 Introductions 
 Study Background 
 IAC Implementation Review 
 Prenatal Intake Interview Form Adaptation 
 Pseudonym Selection 
 Intervention Practice 
 Demographic Information 
 Informed Consent  
 Simulated Clinic Schedule 
 Audio Recording Process 
 Tour of Clinic Locations 
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Appendix J 
Prenatal Intake Interview Form 
NAME:   BIRTH DATE: ___ / ___ / ___       AGE: 
 
RACE:     MARITAL STATUS:    S   M   W   D  SEP 
 
OCCUPATION:  HOMEMAKER     STUDENT      OUTSIDE WORK  TYPE OF WORK:  
 
EDUCATION (LAST GRADE COMPLETED):  
 
HUSBAND/FATHER OF BABY:    
    
 
LMP ___ / ___ / ___  DEFINITE       APPROXIMATE      UNKNOWN   EDD ___ / ___ / ___ 
TOTAL 
PREG 
FULL 
TERM 
 
PREMATURE AB INDUCED AB SPONT ECTOPIC MULT BIRTHS LIVING 
PAST PREGNANCIES 
Date GA 
Wks 
Length of 
Labor 
Birth 
Weight 
Sex 
M/F 
Type 
Delivery 
Anes Place of 
Delivery 
PT Labor 
Yes/No 
Comments/ 
Complications 
          
          
          
          
          
PAST MEDICAL HISTORY 
 0 Neg 
+ Pos 
DETAILS  O Neg 
+ Pos 
DETAIL S 
1. DIABETES   16. D (Rh) SENSITIZED   
2. HYPERTENSION   17. PULMONARY (TB, ASTHMA)   
3. HEART DISEASE   18. ALLERGIES (DRUGS)   
4. AUTOIMM DISORDER   19. BREAST   
5. KIDNEY DIS/ UTI   20. GYN SURGERY   
6. NEURO/EPILEPSY   21. OPERATION/HOSPITALIZATION   
7. PSYCHIATRIC   22. ANESTHETIC COMPLICATIONS   
8. HEPATITIS/LIVER DIS   23. HISTORY OF ABNORMAL PAP   
9. VARICOS/PHLEBITIS   24. UTERINE ANOMALIES/DES   
10. THYROID DYS   25. INFERTILITY   
11. TRAUMA/DOM VIOL   26. RELEVANT FAMILY HX   
12. HX BLOOD TRANS   27. OTHER   
COMMENTS:  
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GENETIC SCREENING/TERATOLOGY COUNSELING 
INCLUDES PATIENT, BABY’S FATHER, OR ANYONE IN EITHER FAMILY 
             YES       NO                YES      NO 
PATIENT’S AGE  35 YEARS   CYSTIC FIBROSIS   
THALESSEMIA   HUNTINGTON CHOREA   
NEURAL TUBE DEFECT   MENTAL RETARDATION/AUTISM   
CONGENITAL HEART DEFECT            IF YES, TESTED FOR FRAGILE X?   
DOWN SYNDROME   OTHER GENETIC/CHROM DISORDER   
TAY-SACHS   MATERNAL METABOLIC DISORDER   
SICKLE CELL DISEASE/TRAIT   
PT OR FOB HAD CHILD WITH  
BIRTH DEFECT NOT LISTED ABOVE? 
  
HEMOPHILIA   RECURRENT PREGNANCY LOSS, OR STILLBIRTH   
MUSCULAR DYSTROPHY   ANY OTHER   
 
COMMENTS/COUNSELING: _________________________________________________________________________________________ 
___________________________________________________________________________________________________________________ 
INFECTION HISTORY YES NO  YES NO 
HIGH RISK HEPATITS B/IMMUNIZED?   RASH/VIRAL ILLNESS SINCE LMP   
EXPOSED TO TB   HISTORY OF STI, GC, HPV, SYPHILIS   
PT/PARTNER HX GENTIAL HERPES   OTHER (SEE COMMENTS)   
 
COMMENTS/: ______________________________________________________________________________________________________ 
___________________________________________________________________________________________________________________ 
NUTRITION  
Number of times per day usually eats? 
1     2     3     4     5     6     7    more often 
 
Daily liquid intake (# of cups/glasses/cans): 
water ____  juice ____  milk ____ 
decaffeinated coffee/tea ____ 
regular coffee/tea ____ 
regular soda/punch ____ decaf soda ____ 
 
Allergic to foods?           No 
 Yes, describe:  
 
Any foods or food groups avoided?          No 
(such as dairy, meat, etc) 
 Yes, list which foods and note reason:  
 
Ever eat raw eggs/fish/meat, soft cheeses,     No 
canned tuna or fish caught by friends or family? 
  
 Yes, describe:  
 
Food or non-food cravings?                            No 
(examples of non-foods are ice, plaster, 
cornstarch, dirt, clay, laundry starch)   
 Yes, describe:  
 
 
Planning to breastfeed? 
 No   combine with formula    not sure      Yes 
Knowledge or experience with breastfeeding? 
 none      observed friends/family    took class    
 personal experience? Circle and comment:     
       negative  positive 
 
 
Currently taking prenatal vitamins?      Yes 
 No, needs vitamins: 
 
Currently taking (if yes; type, amount, frequency):   None  
In addition to prenatal vitamins: 
 over-the-counter drugs: 
 prescription medications: 
 dietary supplements: 
 home remedies: 
 other:  
 
Already enrolled in WIC?        Yes 
 WIC site: _________________ 
 No, needs referral 
Ever run out of food?                       No 
 Yes, describe 
 
 
 151 
Current discomforts?                          No 
 nausea  vomiting   other 
 edema  diarrhea   
 heartburn  constipation 
 
Have access to a working kitchen?       Yes 
 No. Way to cook food? Comment: 
 
Physically active at least 3 times each week? 
 Yes, comment:  
 
 No, comment: 
 
Pre-pregnancy weight: _____ lb   Height: _____ Today’s 
weight _____ lb 
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Appendix K 
Participant Recruitment Letter 
 
 
 
 
 
Dear Care Provider, 
 
I am conducting a research study for my dissertation. The research is to develop a tool 
that will measure implementation of the “I Am Concerned” (IAC) intervention that is 
conducted when a pregnant woman screens positively for prenatal use of alcohol, tobacco 
or illicit drugs. This study is an important first step towards future research to determine 
how effective the IAC is in reducing women’s use of harmful substances. 
 
I am looking for front office staff members (MA, LVN, RN), whose job duties have 
included IAC implementation for at least 2 years, to participate in the study.  Participants 
will attend a half-day IAC refresher training session with me. The actual study portion is 
estimated to last 2 days and will take place in a simulated clinic setting at Cuesta College. 
Participants will be reimbursed for lost wages for work hours missed due to participation 
in the study.   
 
Please call or email me if you are interested in being a part of this research and I can tell 
you more about the study and answer any questions you have.  
 
I sincerely welcome your involvement in this worthwhile effort, 
 
Antonia Torrey RN, MSN 
Duquesne University School of Nursing 
 
Phone: 805 769 6705 
Email: torreya@duq.edu 
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Appendix L 
Participant Demographic Tool 
What is your age in years as of your last birthday? 
________________________ 
 
What is your gender? (Circle number.) 
Female 
Male 
Transgender 
What is your race? 
Non-Hispanic White 
Non-Hispanic Black 
Hispanic/Latino 
Asian & Pacific Islander 
American Indian & Alaska Native 
Other 
What is your present position? 
_____________________________________ 
What is the total number of years you have worked in a prenatal clinic or office? 
________________________ 
What is the total number of years you have implemented the “I Am Concerned” 
intervention? 
_________________________________- 
 
What is your highest level of education? 
 
High School 
Diploma 
Associate degree 
Bachelor’s degree in____________ 
Master’s degree in _____________ 
Doctorate in ______________ 
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Appendix M 
 
 
DUQUESNE UNIVERSITY 
600 FORBES AVENUE      PITTSBURGH, PA 15282 
 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
TITLE:                 Development and Psychometric Evaluation of a 
Structured Instrument to Assess the Treatment 
Fidelity of a Brief Opportunistic Intervention 
Designed to Reduce Substance Use Among 
Pregnant Women 
 
INVESTIGATOR/ADVISOR Linda Goodfellow PhD, RN 
     Associate Professor 
Duquesne University School of Nursing 
School of Nursing 
517 Fisher Hall 
Pittsburgh, PA 15282 
412-396-6548 
 
STUDENT CO-INVESTIGATOR: Antonia Torrey, RN, MSN 
8315 Portola Road 
Atascadero, CA 93422 
 
SOURCE OF SUPPORT: This study is being performed as partial fulfillment 
of the requirements for the Doctor of Philosophy in 
Nursing at Duquesne University 
 
PURPOSE: You are being asked to participate in a research 
project to investigate the usefulness of a research 
instrument that measures the faithfulness with 
which an intervention, designed to reduce prenatal 
use of alcohol, tobacco and other drugs, is 
performed. If you decide to participate in this 
research, you will conduct prenatal interviews in a 
simulated prenatal clinic setting with nursing 
students portraying pregnant women. You will 
follow the process that you use when performing 
your job duties in the prenatal clinic or office in 
which you work, including substance use screening 
and conducting the “I Am Concerned” brief 
opportunistic intervention. Interviews will be audio 
recorded and these recordings will be used during 
the study to evaluate the quality of the research 
instrument referred to above.  
  
RISKS AND BENEFITS: There are no known risks greater than everyday 
activities or direct benefits from participating in this 
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study. However, you will have the knowledge that 
you will help the researchers examine the 
usefulness of a research instrument that measures 
the faithfulness with which an intervention, 
designed to reduce prenatal use of alcohol, tobacco 
and other drugs, is performed.  An indirect benefit 
is the potential reduction in fetal substances 
exposure through dissemination of these study 
findings to a larger health care audience.   
 
COMPENSATION: You will be compensated at approximately your 
normal hourly rate (MA/$12, LVN/$15, RN/$20) 
for wages lost as a result of work hours missed 
while directly participating in this study.  
 
CONFIDENTIALITY: Your name will never appear on any survey or 
research instruments. Your identity will not be 
revealed in the data analysis.  All written materials, 
audiotapes, and consent forms will be stored in a 
locked file cabinet in the researcher's office. The 
consent forms will be kept separate from the other 
research materials. All materials will be destroyed 
at the completion of the research. 
 
RIGHT TO WITHDRAW: You are under no obligation to participate in this 
study.  You are free to withdraw your consent to 
participate at any time. 
 
SUMMARY OF RESULTS: A summary of the results of this research will be 
supplied to you, at no cost, upon request. 
 
VOLUNTARY CONSENT: I have read the above statements and understand 
what is being requested of me.  I also understand 
that my participation is voluntary and that I am free 
to withdraw my consent at any time, for any reason.  
On these terms, I certify that I am willing to 
participate in this research project. I understand that 
should I have any further questions about my 
participation in this study, I may call the Principle 
Investigator and Advisor, Dr. Linda Goodfellow, 
412-396-6548, the Student Co-Investigator, Antonia 
Torrey at 805-769-6705, or Dr. Paul Richer, Chair 
of the Duquesne University Institutional Review 
Board at (412) 396-6326.   
 
_________________________________________   __________________ 
Participant's Signature      Date 
 
_________________________________________   __________________ 
Researcher Signature   Date 
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Appendix N 
Rater Confidentiality Statement 
 
 
 
                         
 
I, _______________________________________, the Research Assistant/Rater, agree 
to: 
 
1. Keep all research information shared with me confidential by not discussing or 
sharing research information in any form or format (audio recordings, fidelity 
measurement instruments) with anyone other than the Researcher or a member of the 
research team. 
 
2. Keep all research information in any form or format (audio recordings, fidelity 
measurement instruments) secure while in my possession. 
 
3. Return all research information in any form or format (audio recordings, fidelity 
measurement instruments) to the Researcher when I have completed the research 
tasks. 
 
 
Research Assistant/Rater 
__________________________  _______________________      ______________ 
Print Name     Signature        Date  
 
 
Researcher 
__________________________  _______________________      ______________ 
Print Name     Signature        Date       
 
 
 
 
 
